{"items": "151", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome", "url": "https://www.globenewswire.com/news-release/2024/12/10/2994352/0/en/AC-Immune-Reports-Interim-Safety-Data-from-Phase-1b-2-ABATE-Trial-of-ACI-24-060-in-Down-syndrome.html", "time_published": "20241210T120000", "authors": ["AC Immune SA"], "summary": "AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome \u2022 ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious adverse events related to the study drug \u2022 No cases of amyloid-related imaging abnormalities ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.141105, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.318897", "ticker_sentiment_score": "0.101865", "ticker_sentiment_label": "Neutral"}]}, {"title": "S&P 500 Moves Lower; US Crude Oil Inventories Increase - DLocal  ( NASDAQ:DLO ) ", "url": "https://www.benzinga.com/news/earnings/24/11/41985303/s-us-crude-oil-inventories-increase", "time_published": "20241114T190847", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 150 points on Thursday. The Dow traded down 0.38% to 43,790.84 while the NASDAQ fell 0.34% to 19,166.29. The S&P 500 also fell, dropping, 0.37% to 5,963.37. Information technology shares rose by ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/14/Wall-Street_2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.714479"}], "overall_sentiment_score": 0.137841, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.175221", "ticker_sentiment_score": "0.262117", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VISL", "relevance_score": "0.175221", "ticker_sentiment_score": "-0.134738", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCT", "relevance_score": "0.175221", "ticker_sentiment_score": "0.153031", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/general/biotech/24/11/41977487/ac-immunes-active-immunotherapy-shows-antibody-responses-in-early-parkinsons-patients", "time_published": "20241114T153249", "authors": ["Vandana Singh"], "summary": "AC Immune SA ACIU revealed data from a Phase 2 clinical trial of its wholly owned anti-alpha-synuclein ( a-syn ) active immunotherapy candidate for early Parkinson's disease.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/14/bz-pharma-briefs.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.256009, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.588876", "ticker_sentiment_score": "0.390233", "ticker_sentiment_label": "Bullish"}, {"ticker": "TAK", "relevance_score": "0.215894", "ticker_sentiment_score": "0.062964", "ticker_sentiment_label": "Neutral"}]}, {"title": "Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday - Huntington Ingalls Indus  ( NYSE:HII ) ", "url": "https://www.benzinga.com/24/11/41976312/hillenbrand-posts-better-than-expected-earnings-joins-beazer-homes-tapestry-walt-disney-and-other-big-stocks-movi", "time_published": "20241114T151138", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Thursday. Shares of Hillenbrand, Inc. HI rose sharply in today's session following upbeat quarterly results. Hillenbrand reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of 92 ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/14/Nvidia--Palantir--Clover-Health--Joby-Av.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.389763, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "NN", "relevance_score": "0.227007", "ticker_sentiment_score": "0.565704", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPIR", "relevance_score": "0.334762", "ticker_sentiment_score": "0.240229", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HI", "relevance_score": "0.436009", "ticker_sentiment_score": "0.41422", "ticker_sentiment_label": "Bullish"}, {"ticker": "JBLU", "relevance_score": "0.227007", "ticker_sentiment_score": "0.548226", "ticker_sentiment_label": "Bullish"}, {"ticker": "WYNN", "relevance_score": "0.227007", "ticker_sentiment_score": "0.144324", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.227007", "ticker_sentiment_score": "0.449704", "ticker_sentiment_label": "Bullish"}, {"ticker": "AAP", "relevance_score": "0.227007", "ticker_sentiment_score": "0.407204", "ticker_sentiment_label": "Bullish"}, {"ticker": "ACIU", "relevance_score": "0.227007", "ticker_sentiment_score": "0.251185", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BZH", "relevance_score": "0.227007", "ticker_sentiment_score": "0.522041", "ticker_sentiment_label": "Bullish"}, {"ticker": "OSCR", "relevance_score": "0.227007", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.227007", "ticker_sentiment_score": "0.368185", "ticker_sentiment_label": "Bullish"}, {"ticker": "TSHA", "relevance_score": "0.227007", "ticker_sentiment_score": "0.407204", "ticker_sentiment_label": "Bullish"}, {"ticker": "ZIM", "relevance_score": "0.227007", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the Jefferies 2024 London Healthcare Conference - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41934735/ac-immune-to-present-at-the-jefferies-2024-london-healthcare-conference", "time_published": "20241113T120000", "authors": ["Globe Newswire"], "summary": "Lausanne, Switzerland, November 13, 2024 - AC Immune SA ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.096242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.507107", "ticker_sentiment_score": "0.082796", "ticker_sentiment_label": "Neutral"}]}, {"title": "Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - Climb Bio  ( NASDAQ:CLYM ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41875065/climb-bio-appoints-douglas-e-williams-ph-d-as-chair-of-the-board", "time_published": "20241111T120000", "authors": ["Globe Newswire"], "summary": "WELLESLEY, Mass., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. CLYM today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio's Chair of its Board of Directors.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.266979, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.055881", "ticker_sentiment_score": "-0.043982", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAKQ", "relevance_score": "0.055881", "ticker_sentiment_score": "-0.043982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.055881", "ticker_sentiment_score": "-0.043982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.111488", "ticker_sentiment_score": "-0.048758", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.055881", "ticker_sentiment_score": "-0.043982", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANA", "relevance_score": "0.055881", "ticker_sentiment_score": "-0.043982", "ticker_sentiment_label": "Neutral"}]}, {"title": "Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board", "url": "https://www.globenewswire.com/news-release/2024/11/11/2978194/0/en/Climb-Bio-Appoints-Douglas-E-Williams-Ph-D-as-Chair-of-the-Board.html", "time_published": "20241111T120000", "authors": ["Climb Bio", "Inc."], "summary": "WELLESLEY, Mass., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. ( Nasdaq: CLYM ) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio's Chair of its Board of Directors. Dr. Williams will assume the role of Chair of the Board, succeeding Andrew Levin, who will remain ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/2a42b557-6e44-4818-bfce-2238a05f2c43", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.215166, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.042717", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAKQ", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.042717", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.042717", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.066877", "ticker_sentiment_score": "-0.045153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.042717", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANA", "relevance_score": "0.033468", "ticker_sentiment_score": "-0.042717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Granite Point Mortgage  ( NYSE:GPMT ) ", "url": "https://www.benzinga.com/news/24/09/40975814/why-granite-point-mortgage-trust-shares-are-trading-higher-here-are-20-stocks-moving-premarket", "time_published": "20240923T094647", "authors": ["Avi Kapoor"], "summary": "Shares of Granite Point Mortgage Trust Inc. GPMT rose sharply in today's pre-market trading after the company announced a third-quarter common and preferred stock dividends. After the market close on Friday, Granite Point Mortgage Trust declared a quarterly cash dividend of 5 cents per share of ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/09/23/movers-image.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.121213, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CERO", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.22515", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CJET", "relevance_score": "0.2256", "ticker_sentiment_score": "0.248723", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MAXN", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.213634", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZJYL", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.22515", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STEM", "relevance_score": "0.151539", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.151539", "ticker_sentiment_score": "0.472685", "ticker_sentiment_label": "Bullish"}, {"ticker": "SMXT", "relevance_score": "0.151539", "ticker_sentiment_score": "0.173895", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GPMT", "relevance_score": "0.297661", "ticker_sentiment_score": "0.30895", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRFX", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.037402", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.151539", "ticker_sentiment_score": "0.083027", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.056333", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGL", "relevance_score": "0.151539", "ticker_sentiment_score": "0.312857", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADTX", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.40131", "ticker_sentiment_label": "Bearish"}, {"ticker": "LGCB", "relevance_score": "0.151539", "ticker_sentiment_score": "0.189288", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GSIW", "relevance_score": "0.151539", "ticker_sentiment_score": "0.054721", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.151539", "ticker_sentiment_score": "0.127288", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGHL", "relevance_score": "0.151539", "ticker_sentiment_score": "0.005832", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHLR", "relevance_score": "0.151539", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2024/09/17/2947287/0/en/AC-Immune-Receives-Second-Milestone-Payment-Following-Progress-in-Phase-2b-ReTain-Trial-of-ACI-35-030-in-Preclinical-Alzheimer-s-Disease.html", "time_published": "20240917T110000", "authors": ["AC Immune SA"], "summary": "AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease \u2022 Potentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic AD \u2022 FDA Fast Track designation granted in ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.168082, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.30021", "ticker_sentiment_score": "0.118133", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.30021", "ticker_sentiment_score": "0.127876", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/09/g40895144/ac-immune-receives-second-milestone-payment-following-progress-in-phase-2b-retain-trial-of-aci-35-", "time_published": "20240917T110000", "authors": ["Globe Newswire"], "summary": "Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic AD FDA Fast Track designation granted in July for ACI-35.030 ( now \"JNJ-2056\" ) ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.16347, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.293038", "ticker_sentiment_score": "0.096752", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.320784", "ticker_sentiment_score": "0.141189", "ticker_sentiment_label": "Neutral"}]}, {"title": "ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal", "url": "https://www.zacks.com/stock/news/2331539/atha-stock-tanks-as-alzheimers-study-fails-to-meet-primary-goal", "time_published": "20240904T153200", "authors": ["Zacks Equity Research"], "summary": "Athira's phase II/III LIFT-AD study on fosgonimeton for treating mild-to-moderate Alzheimer's disease fails to meet primary and secondary endpoints.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.185268, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.084423", "ticker_sentiment_score": "0.120998", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHA", "relevance_score": "0.167904", "ticker_sentiment_score": "-0.126406", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.084423", "ticker_sentiment_score": "0.120998", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.249531", "ticker_sentiment_score": "0.223805", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.328455", "ticker_sentiment_score": "0.369796", "ticker_sentiment_label": "Bullish"}, {"ticker": "SAVA", "relevance_score": "0.084423", "ticker_sentiment_score": "0.120998", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2316892/ac-immune-aciu-reports-q2-loss-lags-revenue-estimates", "time_published": "20240806T132504", "authors": ["Zacks Equity Research"], "summary": "AC Immune (ACIU) delivered earnings and revenue surprises of -159.52% and 99.17%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default263.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.094144, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.412298", "ticker_sentiment_score": "0.042162", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.213674", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate  ( ADC )  Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/07/g40066744/ac-immune-unveils-novel-therapeutic-antibody-drug-conjugate-adc-technology-for-improved-efficacy-i", "time_published": "20240731T123000", "authors": ["Globe Newswire"], "summary": "morADC combines proprietary brain-penetrant small molecule Morphomers\u00ae with SupraAntigen\u00ae monoclonal antibodies, forming a new class of drug-candidates to target toxic proteins in CNS", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.129729, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.326932", "ticker_sentiment_score": "0.146676", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune's ACI-35.030  ( now \"JNJ-2056\" )  Granted FDA Fast Track Designation for Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2024/07/25/2918683/0/en/AC-Immune-s-ACI-35-030-now-JNJ-2056-Granted-FDA-Fast-Track-Designation-for-Alzheimer-s-Disease.html", "time_published": "20240725T110000", "authors": ["AC Immune SA"], "summary": "\u2022 Treatment of first randomized person with preclinical AD expected this quarter \u2022 Phase 2b ReTain trial is fully funded and conducted by development partner", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.143094, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.296761", "ticker_sentiment_score": "0.157983", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.261117", "ticker_sentiment_score": "0.005879", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate  ( morADC )  Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/07/g39789042/ac-immune-showcasing-its-novel-morphomer-antibody-drug-conjugate-moradc-platform-for-the-treatment", "time_published": "20240716T110000", "authors": ["Globe Newswire"], "summary": "Three oral presentations at the Alzheimer's Association International Conference ( AAIC 2024 ) , including talks on morADC, ACI-24.060, and ACI-19626", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.084369, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.534664", "ticker_sentiment_score": "0.117713", "ticker_sentiment_label": "Neutral"}]}, {"title": "Eli Lilly  ( LLY )  Gets FDA Nod for Alzheimer's Drug Donanemab", "url": "https://www.zacks.com/stock/news/2296481/eli-lilly-lly-gets-fda-nod-for-alzheimers-drug-donanemab", "time_published": "20240703T123400", "authors": ["Zacks Equity Research"], "summary": "Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.06643, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.055621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.219809", "ticker_sentiment_score": "0.047636", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.165788", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.219809", "ticker_sentiment_score": "0.251132", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.165788", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?", "url": "https://www.zacks.com/stock/news/2290613/can-eli-lilly-etfs-surge-on-approval-of-alzheimers-drug", "time_published": "20240619T170000", "authors": ["Sanghamitra Saha"], "summary": "On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.146612, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.084722", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.405215", "ticker_sentiment_score": "0.198809", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRTA", "relevance_score": "0.250386", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.250386", "ticker_sentiment_score": "0.060737", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.16849", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab  ( Revised ) ", "url": "https://www.zacks.com/stock/news/2288637/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab-revised", "time_published": "20240614T152100", "authors": ["Zacks Investment Research"], "summary": "If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default301.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.14108, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.049221", "ticker_sentiment_score": "0.050434", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.195025", "ticker_sentiment_score": "0.185819", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRTA", "relevance_score": "0.146916", "ticker_sentiment_score": "0.06373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.195025", "ticker_sentiment_score": "0.250374", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.421485", "ticker_sentiment_score": "0.298879", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.146916", "ticker_sentiment_score": "0.038672", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune  ( Revised ) ", "url": "https://www.zacks.com/stock/news/2288638/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune-revised", "time_published": "20240614T151000", "authors": ["Zacks Investment Research"], "summary": "Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default58.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.147698, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.132855", "ticker_sentiment_score": "0.034244", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.176502", "ticker_sentiment_score": "0.142834", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.176502", "ticker_sentiment_score": "0.040747", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.176502", "ticker_sentiment_score": "0.233404", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.422897", "ticker_sentiment_score": "0.251811", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.088799", "ticker_sentiment_score": "0.035045", "ticker_sentiment_label": "Neutral"}]}, {"title": "RH Posts Mixed Q1 Results, Joins MSC Industrial Direct And Other Big Stocks Moving Lower In Friday's Pre-Market Session - RH  ( NYSE:RH ) ", "url": "https://www.benzinga.com/news/24/06/39328375/rh-posts-mixed-q1-results-joins-msc-industrial-direct-and-other-big-stocks-moving-lower-in-fridays-p", "time_published": "20240614T095026", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were lower this morning, with the Dow futures falling around 250 points on Friday. Shares of RH RH fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/14/xrdDAFekDI-j282-j1745615867-t23032908.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": -0.034699, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.118855", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLAY", "relevance_score": "0.238133", "ticker_sentiment_score": "0.083191", "ticker_sentiment_label": "Neutral"}, {"ticker": "DV", "relevance_score": "0.120431", "ticker_sentiment_score": "0.082854", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSM", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.161104", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RH", "relevance_score": "0.455525", "ticker_sentiment_score": "-0.065276", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.048379", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORN", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.118855", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.238133", "ticker_sentiment_score": "-0.351125", "ticker_sentiment_label": "Bearish"}, {"ticker": "PINS", "relevance_score": "0.350564", "ticker_sentiment_score": "0.176056", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune", "url": "https://www.zacks.com/stock/news/2287623/the-zacks-analyst-blog-highlights-biogen-eli-lillys-prothena-and-ac-immune", "time_published": "20240613T100900", "authors": ["Zacks Investment Research"], "summary": "Biogen, Eli Lilly's, Prothena and AC Immune are included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.152173, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.18046", "ticker_sentiment_score": "0.029956", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.18046", "ticker_sentiment_score": "0.145093", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.18046", "ticker_sentiment_score": "0.041398", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.18046", "ticker_sentiment_score": "0.23699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.431554", "ticker_sentiment_score": "0.255128", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.045482", "ticker_sentiment_score": "0.057891", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab", "url": "https://www.zacks.com/stock/news/2287324/alzheimers-in-focus-as-fda-panel-endorses-lillys-donanemab", "time_published": "20240612T142200", "authors": ["Zacks Investment Research"], "summary": "If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.147923, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.150592", "ticker_sentiment_score": "0.039243", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.199859", "ticker_sentiment_score": "0.189231", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRTA", "relevance_score": "0.150592", "ticker_sentiment_score": "0.064671", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.199859", "ticker_sentiment_score": "0.254862", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.431065", "ticker_sentiment_score": "0.303139", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.050465", "ticker_sentiment_score": "0.050549", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday - AC Immune  ( NASDAQ:ACIU ) , Ambarella  ( NASDAQ:AMBA ) ", "url": "https://www.benzinga.com/news/24/05/39113059/ambarella-posts-upbeat-results-joins-gap-pagerduty-elastic-and-other-big-stocks-moving-higher-on-fri", "time_published": "20240531T144033", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Friday. Shares of Ambarella, Inc. AMBA rose sharply during Friday's session following strong first-quarter earnings and upbeat second-quarter guidance.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/31/xrdDAFkez9BskM2-j7952622998620176998-t23.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.281075, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JWN", "relevance_score": "0.169676", "ticker_sentiment_score": "0.282381", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASAN", "relevance_score": "0.252114", "ticker_sentiment_score": "0.027829", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.169676", "ticker_sentiment_score": "0.460667", "ticker_sentiment_label": "Bullish"}, {"ticker": "COO", "relevance_score": "0.169676", "ticker_sentiment_score": "0.31605", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TDS", "relevance_score": "0.169676", "ticker_sentiment_score": "0.460667", "ticker_sentiment_label": "Bullish"}, {"ticker": "JANX", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLYX", "relevance_score": "0.252114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDI", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRMR", "relevance_score": "0.252114", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPS", "relevance_score": "0.169676", "ticker_sentiment_score": "0.44931", "ticker_sentiment_label": "Bullish"}, {"ticker": "ELV", "relevance_score": "0.169676", "ticker_sentiment_score": "0.460667", "ticker_sentiment_label": "Bullish"}, {"ticker": "USM", "relevance_score": "0.252114", "ticker_sentiment_score": "0.005872", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.252114", "ticker_sentiment_score": "0.181605", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PENN", "relevance_score": "0.169676", "ticker_sentiment_score": "0.097358", "ticker_sentiment_label": "Neutral"}, {"ticker": "PD", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.331765", "ticker_sentiment_score": "0.280335", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.085324", "ticker_sentiment_score": "0.003146", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.169676", "ticker_sentiment_score": "0.501635", "ticker_sentiment_label": "Bullish"}]}, {"title": "AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024", "url": "https://www.globenewswire.com/news-release/2024/05/28/2888855/0/en/AC-Immune-to-Present-at-the-Jefferies-Global-Healthcare-Conference-in-June-2024.html", "time_published": "20240528T110000", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the Jefferies Global Healthcare Conference in June ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.075179, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.512093", "ticker_sentiment_score": "0.067381", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g39034970/ac-immune-to-present-at-the-jefferies-global-healthcare-conference-in-june-2024", "time_published": "20240528T110000", "authors": ["Globe Newswire"], "summary": "Lausanne, Switzerland, May 28, 2023 - AC Immune SA ACIU, a clinical-stage biopharmaceutical company pioneering the development of precision medicine approaches for the diagnosis, treatment, and prevention of neurodegenerative diseases, today announced that Company Management will participate in ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.09406, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.442522", "ticker_sentiment_score": "0.061423", "ticker_sentiment_label": "Neutral"}]}, {"title": "InnovationRx: Battle Of The AI Medical Scribes", "url": "https://www.forbes.com/sites/katiejennings/2024/05/15/innovationrx-battle-of-the-ai-medical-scribes/", "time_published": "20240515T203829", "authors": ["Alex Knapp"], "summary": "InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Augmedix, the only publicly-traded AI medical scribe company, posted $13.5 million in revenue in the first quarter of 2024, up 40% from the previous year.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/664516717dd3c9b4d240018b/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.0601, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.039811", "ticker_sentiment_score": "0.160065", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.039811", "ticker_sentiment_score": "0.044329", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.119038", "ticker_sentiment_score": "0.187627", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HCA", "relevance_score": "0.039811", "ticker_sentiment_score": "0.033191", "ticker_sentiment_label": "Neutral"}, {"ticker": "WXXWY", "relevance_score": "0.039811", "ticker_sentiment_score": "0.088118", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUGX", "relevance_score": "0.197091", "ticker_sentiment_score": "0.012767", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.039811", "ticker_sentiment_score": "0.010771", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.039811", "ticker_sentiment_score": "0.149166", "ticker_sentiment_label": "Neutral"}]}, {"title": "DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - DLocal  ( NASDAQ:DLO ) ", "url": "https://www.benzinga.com/news/24/05/38837718/dlocal-allogene-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session", "time_published": "20240515T101221", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday. Shares of DLocal Limited DLO fell sharply in today's pre-market trading after the company reported weaker-than-expected first-quarter earnings and said there is a greater likelihood ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/15/xrdDAFfORZ4lNo2-j2185570849-t23040509.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.05686, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.334762", "ticker_sentiment_score": "0.321215", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALLO", "relevance_score": "0.334762", "ticker_sentiment_score": "0.129047", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBR", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.330614", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SPCE", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.297393", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MTC", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.081485", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXT", "relevance_score": "0.227007", "ticker_sentiment_score": "0.080908", "ticker_sentiment_label": "Neutral"}]}, {"title": "Gold Down Over 1%; AC Immune Shares Spike Higher - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38798275/gold-down-over-1-ac-immune-shares-spike-higher", "time_published": "20240513T183251", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 50 points on Monday. The Dow traded down 0.15% to 39,453.60 while the NASDAQ rose 0.21% to 16,375.08. The S&P 500 also fell, dropping, 0.06% to 5,219.74. Information technology shares rose by 0.7% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/13/Businessman-Tablet-Stocks-Shutterstock.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.110564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.138066", "ticker_sentiment_score": "0.318061", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMPX", "relevance_score": "0.138066", "ticker_sentiment_score": "-0.070038", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.33628", "ticker_sentiment_score": "0.10316", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.138066", "ticker_sentiment_score": "-0.066772", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCLD", "relevance_score": "0.138066", "ticker_sentiment_score": "0.280608", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SRG-P-A", "relevance_score": "0.069294", "ticker_sentiment_score": "0.09647", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday? - AC Immune  ( NASDAQ:ACIU ) , Takeda Pharmaceutical  ( NYSE:TAK ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38797408/why-is-small-cap-alzheimers-focused-ac-immune-stock-trading-higher-on-monday", "time_published": "20240513T174629", "authors": ["Vandana Singh"], "summary": "Monday, Takeda Pharmaceutical Company Limited TAK and AC Immune SA ACIU announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies targeting toxic forms of amyloid beta ( Abeta ) , including ACI-24.060 for Alzheimer's disease.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/13/Brain-Degenerative-Diseases-Parkinson--A.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.149641, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.716023", "ticker_sentiment_score": "0.304071", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TAK", "relevance_score": "0.240489", "ticker_sentiment_score": "0.068487", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update", "url": "https://www.globenewswire.com/news-release/2024/05/13/2880203/0/en/AC-Immune-Reports-First-Quarter-2024-Financial-Results-and-Provides-a-Corporate-Update.html", "time_published": "20240513T100500", "authors": ["AC Immune SA"], "summary": "AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update \u2022 Landmark deal announced with Takeda for ACI-24.060 with $100 million upfront and total potential payments for option exercise and milestones of up to approximately $2.1 billion \u2022 ACI-24.060 ABATE Phase 2 ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.137465, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.417995", "ticker_sentiment_score": "0.193249", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease - AC Immune  ( NASDAQ:ACIU ) , Takeda Pharmaceutical  ( NYSE:TAK ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38783373/ac-immune-and-takeda-sign-exclusive-option-and-license-agreement-for-active-immunotherapy-targetin", "time_published": "20240513T100000", "authors": ["Globe Newswire"], "summary": "Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer's disease progression", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.986564"}], "overall_sentiment_score": 0.178753, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.314374", "ticker_sentiment_score": "0.187453", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CURN", "relevance_score": "0.017942", "ticker_sentiment_score": "0.085092", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.035875", "ticker_sentiment_score": "0.032077", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2024/05/13/2880195/0/en/AC-Immune-and-Takeda-Sign-Exclusive-Option-and-License-Agreement-for-Active-Immunotherapy-Targeting-Amyloid-Beta-for-Alzheimer-s-Disease.html", "time_published": "20240513T100000", "authors": ["AC Immune SA"], "summary": "AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease \u2022 Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.972476"}], "overall_sentiment_score": 0.183554, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.310382", "ticker_sentiment_score": "0.205816", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CURN", "relevance_score": "0.018743", "ticker_sentiment_score": "0.085509", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.018743", "ticker_sentiment_score": "0.017806", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Upgraded by StockNews.com to Hold", "url": "https://www.defenseworld.net/2024/05/09/ac-immune-nasdaqaciu-upgraded-by-stocknews-com-to-hold.html", "time_published": "20240509T103855", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of AC Immune ( NASDAQ:ACIU - Free Report ) from a sell rating to a hold rating in a report published on Wednesday. Separately, HC Wainwright reissued a buy rating and set a $16.00 price objective on shares of AC Immune in a research report on Friday, March 15th.", "banner_image": "https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.342625, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.833329", "ticker_sentiment_score": "0.547572", "ticker_sentiment_label": "Bullish"}, {"ticker": "PHM", "relevance_score": "0.084722", "ticker_sentiment_score": "0.153455", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New Opportunities - Outcome Potential, Technology Environment, Target Solutions", "url": "https://www.prnewswire.com/news-releases/world-cancer-immunotherapy-market-research-2023-2027-curing-cancer-is-generating-enormous-new-opportunities---outcome-potential-technology-environment-target-solutions-302090249.html", "time_published": "20240316T014500", "authors": ["Research and Markets"], "summary": "World Cancer Immunotherapy Market Research 2023-2027: Curing Cancer is Generating Enormous New ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.104681, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.089797", "ticker_sentiment_score": "0.260532", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update", "url": "https://www.globenewswire.com/news-release/2024/03/14/2846139/0/en/AC-Immune-Reports-Full-Year-2023-Financial-Results-and-Provides-a-Corporate-Update.html", "time_published": "20240314T110000", "authors": ["AC Immune SA"], "summary": "AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update \u2022 ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2 \u2022 ACI-7104.056 VacSYn Phase 2 trial in Parkinson's disease on track for interim data in H2 \u2022 Cash of CHF 103 million at year end, ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.130867, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.265934", "ticker_sentiment_score": "0.102851", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.020848", "ticker_sentiment_score": "0.03387", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.041682", "ticker_sentiment_score": "0.048052", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie  ( ABBV )  Announces Appointment of New CEO Robert Michael", "url": "https://www.zacks.com/stock/news/2229455/abbvie-abbv-announces-appointment-of-new-ceo-robert-michael", "time_published": "20240221T154300", "authors": ["Zacks Equity Research"], "summary": "Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/db/3038.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.219621, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.343755", "ticker_sentiment_score": "0.168325", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CERE", "relevance_score": "0.210579", "ticker_sentiment_score": "0.172638", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.714592", "ticker_sentiment_score": "0.343678", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.070935", "ticker_sentiment_score": "0.065297", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.406745", "ticker_sentiment_score": "0.231943", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pfizer's  ( PFE )  Ulcerative Colitis Pill Velsipity Gets EU Nod", "url": "https://www.zacks.com/stock/news/2228287/pfizers-pfe-ulcerative-colitis-pill-velsipity-gets-eu-nod", "time_published": "20240220T120900", "authors": ["Zacks Equity Research"], "summary": "The approval for Pfizer's (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52 and ELEVATE 12.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.96136"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.177934, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.298749", "ticker_sentiment_score": "0.138016", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMA", "relevance_score": "0.408791", "ticker_sentiment_score": "0.199123", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.354741", "ticker_sentiment_score": "0.245922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.354741", "ticker_sentiment_score": "0.193507", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Down -35.7% in 4 Weeks, Here's Why AC Immune  ( ACIU )  Looks Ripe for a Turnaround", "url": "https://www.zacks.com/stock/news/2217856/down--357-in-4-weeks-heres-why-ac-immune-aciu-looks-ripe-for-a-turnaround", "time_published": "20240130T143503", "authors": ["Zacks Equity Research"], "summary": "The heavy selling pressure might have exhausted for AC Immune (ACIU) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default54.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.996023"}], "overall_sentiment_score": 0.18711, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.48028", "ticker_sentiment_score": "0.241065", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( ACIU )  is a Great Momentum Stock: Should You Buy?", "url": "https://www.zacks.com/stock/news/2212344/ac-immune-aciu-is-a-great-momentum-stock-should-you-buy", "time_published": "20240118T170005", "authors": ["Zacks Equity Research"], "summary": "Does AC Immune (ACIU) have what it takes to be a top stock pick for momentum investors? Let's find out.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default349.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.320777, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.59404", "ticker_sentiment_score": "0.414479", "ticker_sentiment_label": "Bullish"}]}, {"title": "5 Small-Cap Stocks to Play the January Effect", "url": "https://www.zacks.com/stock/news/2207002/5-small-cap-stocks-to-play-the-january-effect", "time_published": "20240108T145900", "authors": ["Sweta Killa"], "summary": "Anavex Life Sciences (AVXL), Peakstone Realty Trust (PKST), AC Immune (ACIU), Getaround (GETR) and Akoya Biosciences (AKYA) could be solid picks to play the January Effect.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/af/3590.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99793"}], "overall_sentiment_score": 0.145244, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.257805", "ticker_sentiment_score": "0.144147", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKYA", "relevance_score": "0.257805", "ticker_sentiment_score": "0.184705", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GETR", "relevance_score": "0.207571", "ticker_sentiment_score": "0.125548", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTAA", "relevance_score": "0.156461", "ticker_sentiment_score": "0.10469", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.257805", "ticker_sentiment_score": "0.105742", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Upgraded to Buy: Here's Why", "url": "https://www.zacks.com/stock/news/2205159/ac-immune-aciu-upgraded-to-buy-heres-why", "time_published": "20240103T170006", "authors": ["Zacks Equity Research"], "summary": "AC Immune (ACIU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default312.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.316575, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.360752", "ticker_sentiment_score": "0.334535", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases", "url": "https://www.globenewswire.com/news-release/2024/01/03/2803284/0/en/AC-Immune-Progress-Update-on-Phase-2-Active-Immunotherapy-Clinical-Pipeline-for-Alzheimer-s-and-Parkinson-diseases.html", "time_published": "20240103T131000", "authors": ["AC Immune SA"], "summary": "AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases \u2022 ABATE Phase 1b/2 AD trial of ACI-24.060 completed enrollment of cohorts 1 and 2 and is expected to complete cohort 3 in January.", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.173873, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.377142", "ticker_sentiment_score": "0.198711", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36467877/ac-immune-progress-update-on-phase-2-active-immunotherapy-clinical-pipeline-for-alzheimers-and-par", "time_published": "20240103T131000", "authors": ["Globe Newswire"], "summary": "ABATE Phase 1b/2 AD trial of ACI-24.060 completed enrollment of cohorts 1 and 2 and is expected to complete cohort 3 in January; 6-month and 12-month amyloid PET data expected in H1 & H2 2024, respectively ReTain Phase 2b clinical trial of ACI-35.030 in preclinical AD being launched now by partner", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.157571, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.347127", "ticker_sentiment_score": "0.165923", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial", "url": "https://www.benzinga.com/node/36256704", "time_published": "20231215T155843", "authors": ["", "S", "g", "d", "a", "n", "h", "i", "V"], "summary": "AC Immune SA's ( NASDAQ: ACIU ) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 ( JNJ-64042056 ) in patients with preclinical Alzheimer's disease ( AD ) , those individuals not yet showing symptoms.", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2023/12/15/aciu.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.101153, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.619618", "ticker_sentiment_score": "0.190065", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.401331", "ticker_sentiment_score": "0.165157", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Announces Pricing of Underwritten Offering of Common Shares - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36255508/ac-immune-announces-pricing-of-underwritten-offering-of-common-shares", "time_published": "20231215T125606", "authors": ["Globe Newswire"], "summary": "Lausanne, Switzerland, December 15, 2023 - AC Immune SA ACIU ( the \"Company\" or \"AC Immune\" ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it has priced an underwritten offering of 14.3 million of its common ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.928769"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.077632, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.321498", "ticker_sentiment_score": "0.039663", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.041323", "ticker_sentiment_score": "0.061103", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Announces Pricing of Underwritten Offering of Common Shares", "url": "https://www.globenewswire.com/news-release/2023/12/15/2797008/0/en/AC-Immune-Announces-Pricing-of-Underwritten-Offering-of-Common-Shares.html", "time_published": "20231215T125600", "authors": ["AC Immune SA"], "summary": "Lausanne, Switzerland, December 15, 2023 - AC Immune SA ( Nasdaq: ACIU ) ( the \"Company\" or \"AC Immune\" ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it has priced an underwritten offering of 14.3 million of its ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.875462"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.077667, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.364275", "ticker_sentiment_score": "0.033363", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.041975", "ticker_sentiment_score": "0.064166", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36255065/ac-immunes-targeted-anti-ptau-active-immunotherapy-for-alzheimers-disease-advances-into-phase-2b-t", "time_published": "20231215T122247", "authors": ["Globe Newswire"], "summary": "Potentially registration-enabling Phase 2b study ( ReTain ) will evaluate the effect of ACI-35.030 on cognition and Tau pathology in approximately 500 participants with preclinical Alzheimer's disease ( AD )", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.133632, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.310843", "ticker_sentiment_score": "0.156537", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.10607", "ticker_sentiment_score": "0.050182", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial", "url": "https://www.globenewswire.com/news-release/2023/12/15/2796982/0/en/AC-Immune-s-Targeted-Anti-pTau-Active-Immunotherapy-for-Alzheimer-s-Disease-Advances-into-Phase-2b-Trial.html", "time_published": "20231215T122200", "authors": ["AC Immune SA"], "summary": "\u2022 Potentially registration-enabling Phase 2b study ( ReTain ) will evaluate the effect of ACI-35.030 on cognition and Tau pathology in approximately 500 participants with preclinical Alzheimer's disease ( AD ) \u2022 Anti-pTau active immunotherapy being designed to potentially prevent or reduce ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.138392, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.291707", "ticker_sentiment_score": "0.144885", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.081276", "ticker_sentiment_score": "0.050176", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity", "url": "https://www.zacks.com/stock/news/2196695/the-zacks-analyst-blog-highlights-biogen-prothena-ac-immunes-and-vaxxinity", "time_published": "20231212T141000", "authors": ["Zacks Equity Research"], "summary": "Biogen, Prothena, AC Immune's and Vaxxinity are part of the Zacks top Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/20/15392.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.191433, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.128592", "ticker_sentiment_score": "-0.017717", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.212674", "ticker_sentiment_score": "0.08018", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.037015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.04303", "ticker_sentiment_score": "0.124792", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.170878", "ticker_sentiment_score": "0.131235", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alzheimer's Disease Space Evolves in 2023: Stocks in Focus", "url": "https://www.zacks.com/stock/news/2196083/alzheimers-disease-space-evolves-in-2023-stocks-in-focus", "time_published": "20231211T140600", "authors": ["Ekta Bagri"], "summary": "The approval of the breakthrough treatment Leqembi for Alzheimer's Disease has put this space in the spotlight. Companies like ACIU, VAXX and PRTA are in focus, given their experimental vaccines.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c2/53795.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.201058, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.136888", "ticker_sentiment_score": "0.061186", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.181819", "ticker_sentiment_score": "0.109759", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.061265", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.04583", "ticker_sentiment_score": "0.124967", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.136888", "ticker_sentiment_score": "0.191134", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is it a Good Idea to Invest in AC Immune  ( ACIU )  Stock Now?", "url": "https://www.zacks.com/stock/news/2193345/is-it-a-good-idea-to-invest-in-ac-immune-aciu-stock-now", "time_published": "20231205T105900", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in AC Immune (ACIU) stock now may turn out to be a prudent move.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.162188, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.472959", "ticker_sentiment_score": "0.172325", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.213674", "ticker_sentiment_score": "0.050324", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.282234", "ticker_sentiment_score": "0.14456", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are Medical Stocks Lagging Aquestive Therapeutics  ( AQST )  This Year?", "url": "https://www.zacks.com/stock/news/2189710/are-medical-stocks-lagging-aquestive-therapeutics-aqst-this-year", "time_published": "20231127T144008", "authors": ["Zacks Equity Research"], "summary": "Here is how Aquestive Therapeutics (AQST) and AC Immune (ACIU) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default72.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.225273, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.391923", "ticker_sentiment_score": "0.166954", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AQST", "relevance_score": "0.751437", "ticker_sentiment_score": "0.399823", "ticker_sentiment_label": "Bullish"}]}, {"title": "Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others - Biogen  ( NASDAQ:BIIB ) ", "url": "https://www.benzinga.com/general/biotech/23/11/35901610/alzheimers-disease-vaccines-promising-developments-renewed-enthusiasm-from-biogen-eli-lilly-and-o", "time_published": "20231121T201625", "authors": ["Vandana Singh"], "summary": "Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins ( white matter ) from the brain have sparked a renewed interest in developing vaccines to combat this memory-robbing disease.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/21/aapharma_5.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.087042, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.229149", "ticker_sentiment_score": "0.303386", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.229149", "ticker_sentiment_score": "-0.07556", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.229149", "ticker_sentiment_score": "0.303386", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VAXX", "relevance_score": "0.229149", "ticker_sentiment_score": "0.303386", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ESALF", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.048396", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.229149", "ticker_sentiment_score": "-0.07556", "ticker_sentiment_label": "Neutral"}]}, {"title": "Researchers return to Alzheimer's vaccines, buoyed by recent drug success", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/", "time_published": "20231120T111500", "authors": ["Julie Steenhuysen"], "summary": "A doctor points out evidence of Alzheimer's disease on PET scans at the Center for Alzheimer Research and Treatment ( CART ) at Brigham And Women's Hospital in Boston, Massachusetts, U.S., March 30, 2023. REUTERS/Brian Snyder/File photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/44DLHLDT6NLKRBD4B3LGYE2GVM.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.077594, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.083251", "ticker_sentiment_score": "-0.021977", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.165598", "ticker_sentiment_score": "0.084646", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.124593", "ticker_sentiment_score": "0.108971", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.028824", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.041682", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.290871", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Are Medical Stocks Lagging AC Immune  ( ACIU )  This Year?", "url": "https://www.zacks.com/stock/news/2181604/are-medical-stocks-lagging-ac-immune-aciu-this-year", "time_published": "20231109T144007", "authors": ["Zacks Equity Research"], "summary": "Here is how AC Immune (ACIU) and Exact Sciences (EXAS) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default320.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.210842, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.778186", "ticker_sentiment_score": "0.306795", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EXAS", "relevance_score": "0.502693", "ticker_sentiment_score": "0.220291", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune to Present at the Jefferies 2023 London Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/11/07/2774887/0/en/AC-Immune-to-Present-at-the-Jefferies-2023-London-Healthcare-Conference.html", "time_published": "20231107T120000", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the Jefferies 2023 London Healthcare Conference", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.065767, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.510838", "ticker_sentiment_score": "0.064062", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer's Disease as a Surrogate of Clinical Efficacy on November 9, 2023 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35558747/ac-immune-to-host-kol-webinar-on-amyloid-plaque-pet-imaging-in-alzheimers-disease-as-a-surrogate-o", "time_published": "20231102T110000", "authors": ["Globe Newswire"], "summary": "Lausanne, Switzerland, November 02, 2023 - AC Immune SA ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will host a KOL webinar on amyloid plaque PET imaging in Alzheimer's Disease as a surrogate of clinical ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.130593, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.349945", "ticker_sentiment_score": "0.078807", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic", "url": "https://www.globenewswire.com/news-release/2023/10/27/2768271/0/en/AC-Immune-Clinical-Data-Published-in-Nature-Communications-Show-Alpha-Synuclein-PET-Tracer-ACI-12589-Has-Potential-as-Neurodegenerative-Disease-Diagnostic.html", "time_published": "20231027T110000", "authors": ["AC Immune SA"], "summary": "PRESS RELEASE ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.158287, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.441698", "ticker_sentiment_score": "0.175919", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is AC Immune  ( ACIU )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2170807/is-ac-immune-aciu-stock-outpacing-its-medical-peers-this-year", "time_published": "20231024T134008", "authors": ["Zacks Equity Research"], "summary": "Here is how AC Immune (ACIU) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.183199, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.747404", "ticker_sentiment_score": "0.262356", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BRSYF", "relevance_score": "0.388879", "ticker_sentiment_score": "0.239229", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Earnings Preview: Qiagen  ( QGEN )  Q3 Earnings Expected to Decline", "url": "https://www.zacks.com/stock/news/2170302/earnings-preview-qiagen-qgen-q3-earnings-expected-to-decline", "time_published": "20231023T140038", "authors": ["Zacks Equity Research"], "summary": "Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.123826, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.174272", "ticker_sentiment_score": "0.047367", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.258808", "ticker_sentiment_score": "-0.015929", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release", "url": "https://www.zacks.com/stock/news/2169670/ac-immune-aciu-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release", "time_published": "20231020T140038", "authors": ["Zacks Equity Research"], "summary": "AC Immune (ACIU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default171.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.144852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.260189", "ticker_sentiment_score": "0.129249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.175221", "ticker_sentiment_score": "-0.001426", "ticker_sentiment_label": "Neutral"}]}, {"title": "NeoGenomics  ( NEO )  Soars 8.9%: Is Further Upside Left in the Stock?", "url": "https://www.zacks.com/stock/news/2167798/neogenomics-neo-soars-89-is-further-upside-left-in-the-stock", "time_published": "20231018T122600", "authors": ["Zacks Equity Research"], "summary": "NeoGenomics (NEO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default80.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.160241, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.455525", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.636698", "ticker_sentiment_score": "0.185249", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Announces Upcoming Presentations at the 16th CTAD Conference - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35283474/ac-immune-announces-upcoming-presentations-at-the-16th-ctad-conference", "time_published": "20231017T110000", "authors": ["Globe Newswire"], "summary": "Lausanne, Switzerland, October 17, 2023 - AC Immune SA ACIU, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the 16th Clinical Trials on Alzheimer's ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.098434, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.543376", "ticker_sentiment_score": "0.148348", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Announces Upcoming Presentations at the 16th CTAD Conference", "url": "https://www.globenewswire.com/news-release/2023/10/17/2761349/0/en/AC-Immune-Announces-Upcoming-Presentations-at-the-16th-CTAD-Conference.html", "time_published": "20231017T110000", "authors": ["AC Immune SA"], "summary": "Lausanne, Switzerland, October 17, 2023 - AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the 16th Clinical Trials on ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.075169, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.534445", "ticker_sentiment_score": "0.065816", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.defenseworld.net/2023/10/06/stocknews-com-initiates-coverage-on-ac-immune-nasdaqaciu.html", "time_published": "20231006T054841", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com started coverage on shares of AC Immune ( NASDAQ:ACIU - Get Free Report ) in a research note issued to investors on Thursday. The brokerage set a \"sell\" rating on the stock.", "banner_image": "https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.352661, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.827318", "ticker_sentiment_score": "0.561221", "ticker_sentiment_label": "Bullish"}, {"ticker": "C", "relevance_score": "0.083541", "ticker_sentiment_score": "0.223524", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XOM", "relevance_score": "0.083541", "ticker_sentiment_score": "0.085881", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023", "url": "https://www.globenewswire.com/news-release/2023/10/05/2755226/0/en/AC-Immune-to-Present-at-the-Jefferies-2023-CNS-Neuro-Summit-in-October-2023.html", "time_published": "20231005T110000", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.065781, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.508345", "ticker_sentiment_score": "0.060664", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Surges 43% in the Past 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2145026/ac-immune-aciu-surges-43-in-the-past-3-months-heres-why", "time_published": "20230905T170900", "authors": ["Zacks Equity Research"], "summary": "AC Immune's (ACIU) shares rose 43% over the past three months, driven by rapid progress in the development of its pipeline candidate, ACI-24.060, for neurodegenerative diseases.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.116592, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.54816", "ticker_sentiment_score": "0.330824", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANVS", "relevance_score": "0.293214", "ticker_sentiment_score": "-0.028422", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORT", "relevance_score": "0.149192", "ticker_sentiment_score": "0.07191", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are Options Traders Betting on a Big Move in AC Immune  ( ACIU )  Stock?", "url": "https://www.zacks.com/stock/news/2144704/are-options-traders-betting-on-a-big-move-in-ac-immune-aciu-stock", "time_published": "20230905T124800", "authors": ["Zacks Equity Research"], "summary": "Investors need to pay close attention to AC Immune (ACIU) stock based on the movements in the options market lately.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/85/351.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.081051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.59016", "ticker_sentiment_score": "0.129069", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34228806/ac-immune-to-present-at-the-h-c-wainwright-25th-annual-global-investment-conference-in-september-2", "time_published": "20230905T110000", "authors": ["Globe Newswire"], "summary": "AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.053999, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.535653", "ticker_sentiment_score": "0.062549", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023", "url": "https://www.globenewswire.com/news-release/2023/09/05/2737128/0/en/AC-Immune-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference-in-September-2023.html", "time_published": "20230905T110000", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.065767, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.496201", "ticker_sentiment_score": "0.059745", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Upgrades AC Immune  ( NASDAQ:ACIU )  to Hold", "url": "https://www.defenseworld.net/2023/08/09/stocknews-com-upgrades-ac-immune-nasdaqaciu-to-hold.html", "time_published": "20230809T071917", "authors": ["Defense World Staff"], "summary": "AC Immune ( NASDAQ:ACIU - Get Free Report ) was upgraded by equities researchers at StockNews.com from a \"sell\" rating to a \"hold\" rating in a research report issued to clients and investors on Monday. Separately, HC Wainwright restated a \"buy\" rating and set a $16.00 target price on shares of ...", "banner_image": "https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.319167, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.904419", "ticker_sentiment_score": "0.527109", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.110462", "ticker_sentiment_score": "0.151295", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( ACIU )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2132610/ac-immune-aciu-reports-q2-loss-misses-revenue-estimates", "time_published": "20230804T121506", "authors": ["Zacks Equity Research"], "summary": "AC Immune (ACIU) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.126114, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.414559", "ticker_sentiment_score": "0.149882", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGND", "relevance_score": "0.214937", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023", "url": "https://www.globenewswire.com/news-release/2023/07/28/2713010/0/en/AC-Immune-to-Present-at-the-BTIG-Virtual-Biotechnology-Conference-2023.html", "time_published": "20230728T110000", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the BTIG Virtual Biotechnology Conference ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.082175, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.545493", "ticker_sentiment_score": "0.106281", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Showcasing Precision Medicine Programs at AAIC 2023 - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33094657/ac-immune-showcasing-precision-medicine-programs-at-aaic-2023", "time_published": "20230703T110000", "authors": ["Globe Newswire"], "summary": "AC Immune Showcasing Precision Medicine Programs at AAIC 2023", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.089208, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.580595", "ticker_sentiment_score": "0.123528", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Showcasing Precision Medicine Programs at AAIC 2023", "url": "https://www.globenewswire.com/news-release/2023/07/03/2698440/0/en/AC-Immune-Showcasing-Precision-Medicine-Programs-at-AAIC-2023.html", "time_published": "20230703T110000", "authors": ["AC Immune SA"], "summary": "AC Immune Showcasing Precision Medicine Programs at ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.086971, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.528798", "ticker_sentiment_score": "0.088095", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Shares of AC Immune Jumped This Week", "url": "https://www.fool.com/investing/2023/06/30/why-shares-of-ac-immune-sa-jumped-this-week/", "time_published": "20230630T191307", "authors": ["Jim Halley"], "summary": "The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F738114%2Fmmm-dividend-stock.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.176263, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.677342", "ticker_sentiment_score": "0.275123", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.130926", "ticker_sentiment_score": "0.117842", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why AC Immune Stock Skyrocketed Today - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/news/23/06/33031846/why-ac-immune-stock-skyrocketed-today", "time_published": "20230627T184905", "authors": ["Ryan Gustafson"], "summary": "AC Immune SA ACIU shares surged Tuesday after the company received FDA Fast Track Designation for its anti-amyloid-beta active immunotherapy, ACI-24.060, for Alzheimer's disease.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/27/syringe-1291129_1280.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.357346, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.766141", "ticker_sentiment_score": "0.752202", "ticker_sentiment_label": "Bullish"}]}, {"title": "AC Immune Holds Annual General Meeting of Shareholders", "url": "https://www.globenewswire.com/news-release/2023/06/23/2693917/0/en/AC-Immune-Holds-Annual-General-Meeting-of-Shareholders.html", "time_published": "20230623T203000", "authors": ["AC Immune SA"], "summary": "\u2022 Shareholders approved all resolutions as proposed by the Board of Directors Lausanne, Switzerland, June 23, 2023 - AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the Company held its ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.093746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.442853", "ticker_sentiment_score": "0.093268", "ticker_sentiment_label": "Neutral"}]}, {"title": "Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research", "url": "https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html", "time_published": "20230515T093200", "authors": ["Brandessence Market Research and Consulting Private Limited"], "summary": "Report Forecasts Promising Future for Alzheimer's Disease Market ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.172476, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.017394", "ticker_sentiment_score": "-0.017349", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHYOF", "relevance_score": "0.017394", "ticker_sentiment_score": "0.117319", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.03478", "ticker_sentiment_score": "0.017283", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.017394", "ticker_sentiment_score": "-0.017349", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.017394", "ticker_sentiment_score": "-0.017349", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.03478", "ticker_sentiment_score": "0.124339", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.017394", "ticker_sentiment_score": "0.117319", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVS", "relevance_score": "0.017394", "ticker_sentiment_score": "0.117319", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.017394", "ticker_sentiment_score": "-0.017349", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.017394", "ticker_sentiment_score": "0.117319", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.017394", "ticker_sentiment_score": "0.112745", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.069495", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.017394", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/04/28/2657303/0/en/AC-Immune-Reports-First-Quarter-2023-Financial-Results-and-Provides-a-Corporate-Update.html", "time_published": "20230428T110000", "authors": ["AC Immune SA"], "summary": "AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update \u2022 ACI-24.060 anti-Abeta vaccine showed positive initial safety and immunogenicity in first Alzheimer's disease ( AD ) cohort in ABATE Phase 1b/2 trial.", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.121933, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.326971", "ticker_sentiment_score": "0.146146", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2023/04/05/2641522/0/en/AC-Immune-to-Host-Key-Opinion-Leader-Webinar-on-Early-Diagnosis-and-Prevention-of-Alzheimer-s-Disease.html", "time_published": "20230405T110000", "authors": ["AC Immune SA"], "summary": "AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer's Disease \u2022 Webinar to take place on Tuesday, April 18, 2023, at 10:30 AM EDT / 4:30 PM CEST", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.051469, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.28636", "ticker_sentiment_score": "0.040021", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Lifted to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/03/25/ac-immune-nasdaqaciu-lifted-to-hold-at-stocknews-com.html", "time_published": "20230325T052041", "authors": ["Defense World Staff"], "summary": "AC Immune ( NASDAQ:ACIU - Get Rating ) was upgraded by StockNews.com from a \"sell\" rating to a \"hold\" rating in a research note issued to investors on Saturday. Separately, HC Wainwright reissued a \"buy\" rating and set a $16.00 price target on shares of AC Immune in a report on Friday, March 17th.", "banner_image": "https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.273766, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.895116", "ticker_sentiment_score": "0.459313", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.183198", "ticker_sentiment_score": "0.255805", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.092213", "ticker_sentiment_score": "-0.039469", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.092213", "ticker_sentiment_score": "0.053022", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune at AD/PD\u2122 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline", "url": "https://www.globenewswire.com/news-release/2023/03/20/2630182/0/en/AC-Immune-at-AD-PD-2023-to-Present-New-Clinical-and-Preclinical-Data-from-its-Precision-Medicine-Pipeline.html", "time_published": "20230320T120000", "authors": ["AC Immune SA"], "summary": "AC Immune at AD/PD\u2122 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline \u2022 Ten presentations at the International Conference on Alzheimer's & Parkinson's Diseases ( AD/PDTM ) \u2022 AC Immune's Chief Medical Officer to participate in expert forum on immunotherapies ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.100652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.61135", "ticker_sentiment_score": "0.10578", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/03/16/2628465/0/en/AC-Immune-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20230316T110000", "authors": ["AC Immune SA"], "summary": "AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update \u2022 Clinical-stage vaccine programs targeting amyloid-beta ( Abeta ) , phosphorylated-Tau ( pTau ) , and alpha-synuclein ( a-syn ) are all on track to reach important milestones in 2023 \u2022 ACI-24.060 anti-amyloid-beta ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.875462"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.180035, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.251767", "ticker_sentiment_score": "0.136134", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.017072", "ticker_sentiment_score": "0.072878", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.017072", "ticker_sentiment_score": "0.072878", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:CHF", "relevance_score": "0.37739", "ticker_sentiment_score": "0.147917", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43", "url": "https://www.globenewswire.com/news-release/2023/02/07/2602787/0/en/AC-Immune-Awarded-New-Grants-from-MJFF-and-Target-ALS-Supporting-Programs-Targeting-TDP-43.html", "time_published": "20230207T120000", "authors": ["AC Immune SA"], "summary": "AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.248464, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.47672", "ticker_sentiment_score": "0.321423", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune to Present at the SVB Securities Global Biopharma Conference", "url": "https://www.benzinga.com/pressreleases/23/02/g30686978/ac-immune-to-present-at-the-svb-securities-global-biopharma-conference", "time_published": "20230202T131500", "authors": ["Globe Newswire"], "summary": "AC Immune to Present at the SVB Securities Global Biopharma Conference", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.077289, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.483686", "ticker_sentiment_score": "0.086562", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the SVB Securities Global Biopharma Conference", "url": "https://www.globenewswire.com/news-release/2023/02/02/2600439/0/en/AC-Immune-to-Present-at-the-SVB-Securities-Global-Biopharma-Conference.html", "time_published": "20230202T131500", "authors": ["AC Immune SA"], "summary": "AC Immune to Present at the SVB Securities Global Biopharma Conference", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.682689"}], "overall_sentiment_score": 0.086672, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.445569", "ticker_sentiment_score": "0.085012", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biogen  ( BIIB )  & Eisai's Lecanemab Secures EMA's MAA Acceptance", "url": "https://www.zacks.com/stock/news/2045510/biogen-biib-eisais-lecanemab-secures-emas-maa-acceptance", "time_published": "20230127T145700", "authors": ["Zacks Investment Research"], "summary": "Biogen (BIIB) and Eisai jointly announce that EMA accepts lecanemab's marketing authorization application (MAA) for the treatment of patients with early-stage Alzheimer's disease, for review.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/20/15392.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.238586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.239305", "ticker_sentiment_score": "0.207135", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.239305", "ticker_sentiment_score": "0.187879", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ESALF", "relevance_score": "0.239305", "ticker_sentiment_score": "0.268463", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACET", "relevance_score": "0.121037", "ticker_sentiment_score": "0.082826", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.352223", "ticker_sentiment_score": "0.292167", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune's ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer's Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial", "url": "https://www.globenewswire.com/news-release/2023/01/26/2595885/0/en/AC-Immune-s-ACI-24-060-Anti-Amyloid-Beta-Vaccine-for-Alzheimer-s-Shows-Positive-Initial-Interim-Safety-and-Immunogenicity-in-Phase-1b-2-ABATE-Trial.html", "time_published": "20230126T120000", "authors": ["AC Immune SA"], "summary": "AC Immune's ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer's Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial \u2022 ACI-24.060 elicited an anti-Abeta antibody response in ABATE's first, low dose cohort \u2022 ACI-24.060 was generally well tolerated with no safety ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.15466, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.283688", "ticker_sentiment_score": "0.116766", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stablix Appoints Douglas Williams, Ph.D., to Board of Directors", "url": "https://www.benzinga.com/pressreleases/23/01/g30458105/stablix-appoints-douglas-williams-ph-d-to-board-of-directors", "time_published": "20230118T120047", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization ( TPS ) as a novel therapeutic modality, today announced the appointment of Douglas E. Williams, Ph.D. to its Board of Directors.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.170557, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.063425", "ticker_sentiment_score": "-0.038049", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.009404", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.063425", "ticker_sentiment_score": "-0.038049", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.063425", "ticker_sentiment_score": "-0.038049", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2023/01/18/2590776/0/en/AC-Immune-Partner-Life-Molecular-Imaging-Initiates-Phase-3-Study-of-Tau-PET-Diagnostic-PI-2620-for-Alzheimer-s-Disease.html", "time_published": "20230118T120000", "authors": ["AC Immune SA"], "summary": "\u2022 First Alzheimer's patient imaged with PI-2620 in ADvance, the pivotal Phase 3 trial \u2022 PI-2620 potentially best-in-class Tau PET tracer with high binding affinity and selectivity for aggregated Tau", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.174923, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.317254", "ticker_sentiment_score": "0.156792", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LTGHF", "relevance_score": "0.032602", "ticker_sentiment_score": "0.118925", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune's Alzheimer's Disease Vaccine-candidate ACI-35.030 Selected for Further Development", "url": "https://www.globenewswire.com/news-release/2022/11/30/2564787/0/en/AC-Immune-s-Alzheimer-s-Disease-Vaccine-candidate-ACI-35-030-Selected-for-Further-Development.html", "time_published": "20221130T120000", "authors": ["AC Immune SA"], "summary": "\u2022 Based on this new clinical data, ACI-35.030 has been selected for further development representing significant progress for the anti-pTau vaccine candidate \u2022 AC Immune vaccine portfolio targeting three hallmark proteins of neurodegenerative diseases now progressing through advanced clinical ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.210609, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.411176", "ticker_sentiment_score": "0.231544", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.035929", "ticker_sentiment_score": "0.056054", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present Progress of Alzheimer's Disease Programs targeting Abeta and Tau at the 15th CTAD Conference - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/22/11/g29837401/ac-immune-to-present-progress-of-alzheimers-disease-programs-targeting-abeta-and-tau-at-the-15th-c", "time_published": "20221123T123000", "authors": ["Globe Newswire"], "summary": "Next generation SupraAntigen\u00ae liposomal vaccine platform augments immunization against pathological targets of Alzheimer's disease New data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity of ACI-35 and JACI-35, developed in collaboration with Janssen Pharmaceuticals", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.08897, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.431956", "ticker_sentiment_score": "0.103182", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.041394", "ticker_sentiment_score": "0.132939", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present Progress of Alzheimer's Disease Programs targeting Abeta and Tau at the 15th CTAD Conference", "url": "https://www.globenewswire.com/news-release/2022/11/23/2561536/0/en/AC-Immune-to-Present-Progress-of-Alzheimer-s-Disease-Programs-targeting-Abeta-and-Tau-at-the-15th-CTAD-Conference.html", "time_published": "20221123T123000", "authors": ["AC Immune SA"], "summary": "Lausanne, Switzerland, November 23, 2022 - AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced the upcoming presentations of its vaccine technology SupraAntigen\u00ae, and of its anti-Tau and ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/0065cdfd-b9fc-4994-8aca-731c1d031b51?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.09612, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.351807", "ticker_sentiment_score": "0.094059", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the Jefferies London Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/11/08/2550839/0/en/AC-Immune-to-Present-at-the-Jefferies-London-Healthcare-Conference.html", "time_published": "20221108T125800", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Nov. 08, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.061018, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.395012", "ticker_sentiment_score": "0.054013", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Reports Q3 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2006533/ac-immune-aciu-reports-q3-loss-tops-revenue-estimates", "time_published": "20221028T132504", "authors": ["Zacks Investment Research"], "summary": "AC Immune (ACIU) delivered earnings and revenue surprises of 29.17% and 457.95%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default333.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.075354, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.412298", "ticker_sentiment_score": "-0.005612", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.213674", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports Third Quarter 2022 Financial Results and Provides a Corporate Update", "url": "https://www.globenewswire.com/news-release/2022/10/28/2543792/0/en/AC-Immune-Reports-Third-Quarter-2022-Financial-Results-and-Provides-a-Corporate-Update.html", "time_published": "20221028T120000", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Oct. 28, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported results for the third quarter ended September 30, 2022, and provided a corporate ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.795202"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.133542, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.163631", "ticker_sentiment_score": "0.07017", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.041181", "ticker_sentiment_score": "0.0565", "ticker_sentiment_label": "Neutral"}]}, {"title": "Analysts at StockNews.com rate AC Immune  ( NASDAQ:ACIU )  as a hold.", "url": "https://beststocks.com/analysts-at-stocknews-com-rate-ac-immune-nasdaqa/", "time_published": "20221016T224723", "authors": ["Yasmim Mendon\u00e7a"], "summary": "The coverage of AC Immune was initiated by the research analysts at StockNews.com on Saturday in the form of a research note that was sent out to investors via email ( NASDAQ: ACIU ) . As a result, the company has recommended that investors \"hold\" onto their shares for the time being.", "banner_image": "https://beststocks.com/wp-content/uploads/2022/07/Dow-Jones.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "beststocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999365"}, {"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.223776, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.78997", "ticker_sentiment_score": "0.367423", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.132733", "ticker_sentiment_score": "0.179346", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.132733", "ticker_sentiment_score": "0.179346", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:SEK", "relevance_score": "0.066598", "ticker_sentiment_score": "0.150523", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Receives New Coverage from Analysts at StockNews.com", "url": "https://reporter.am/2022/10/07/ac-immune-nasdaqaciu-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20221007T065042", "authors": ["AM Reporter Staff"], "summary": "StockNews.com started coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a report released on Friday. The firm set a \"hold\" rating on the stock. ACIU has been the topic of several other reports.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.261766, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.920325", "ticker_sentiment_score": "0.445187", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.163354", "ticker_sentiment_score": "0.255164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BOX", "relevance_score": "0.082111", "ticker_sentiment_score": "0.096337", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.082111", "ticker_sentiment_score": "0.193483", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.163354", "ticker_sentiment_score": "0.255164", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating ACI-24 Targeting Abeta in Alzheimer's Disease and Down Syndrome", "url": "https://www.globenewswire.com/news-release/2022/10/04/2527812/0/en/AC-Immune-Opens-New-Centers-in-Phase-1b-2-Trial-Evaluating-ACI-24-Targeting-Abeta-in-Alzheimer-s-Disease-and-Down-Syndrome.html", "time_published": "20221004T123600", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Oct. 04, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today provided an update on the Phase 1b/2 ABATE study of its anti-amyloid-beta ( Abeta ) vaccine ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.165794, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.328554", "ticker_sentiment_score": "0.140334", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Research Coverage Started at StockNews.com", "url": "https://www.etfdailynews.com/2022/09/29/ac-immune-nasdaqaciu-research-coverage-started-at-stocknews-com-2/", "time_published": "20220929T060845", "authors": ["MarketBeat News"], "summary": "Equities research analysts at StockNews.com initiated coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research note issued on Thursday. The firm set a \"hold\" rating on the stock. Several other equities analysts also recently weighed in on the company.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.205632, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.859433", "ticker_sentiment_score": "0.349315", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNFI", "relevance_score": "0.083833", "ticker_sentiment_score": "0.032062", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.083833", "ticker_sentiment_score": "0.184781", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MULN", "relevance_score": "0.083833", "ticker_sentiment_score": "0.032062", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.166743", "ticker_sentiment_score": "0.244286", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win - Biogen  ( NASDAQ:BIIB ) ", "url": "https://www.benzinga.com/general/biotech/22/09/29061026/these-stocks-are-on-the-radar-after-biogen-eisais-surprising-alzheimers-trial-win", "time_published": "20220928T201722", "authors": ["Vandana Singh"], "summary": "One of the most-watched Alzheimer's therapies in the clinic, Biogen Inc BIIB-Eisai Limited's ESALY experimental lecanemab reduced clinical decline on the scale by 27% compared to the placebo at 18 months in early Alzheimer's.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/09/28/aapharma_17.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.131295, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALZN", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.167709", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGVN", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOR", "relevance_score": "0.112269", "ticker_sentiment_score": "-0.03398", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGTX", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.056275", "ticker_sentiment_score": "-0.085904", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.112269", "ticker_sentiment_score": "-0.094787", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.112269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Partner LMI Progresses Tau PET Tracer PI-2620 into Late-stage Development in Alzheimer's Disease - AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.benzinga.com/pressreleases/22/09/g29005806/ac-immune-partner-lmi-progresses-tau-pet-tracer-pi-2620-into-late-stage-development-in-alzheimers-", "time_published": "20220926T113000", "authors": ["Globe Newswire"], "summary": "AC Immune's Tau PET tracer moves closer to becoming a next generation diagnostic for Alzheimer's Disease ( AD ) AC Immune to receive a milestone payment from LMI for progress into late-stage product development", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.145212, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.361626", "ticker_sentiment_score": "0.140588", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTGHF", "relevance_score": "0.031241", "ticker_sentiment_score": "0.108443", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Now Covered by Analysts at StockNews.com", "url": "https://reporter.am/2022/09/22/ac-immune-nasdaqaciu-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20220922T075442", "authors": ["AM Reporter Staff"], "summary": "StockNews.com began coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock. Several other research analysts have also recently weighed in on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.313148, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.88438", "ticker_sentiment_score": "0.516386", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.166169", "ticker_sentiment_score": "0.285312", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNJ", "relevance_score": "0.083541", "ticker_sentiment_score": "0.216708", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.166169", "ticker_sentiment_score": "0.285312", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Research Coverage Started at StockNews.com", "url": "https://www.etfdailynews.com/2022/09/21/ac-immune-nasdaqaciu-research-coverage-started-at-stocknews-com/", "time_published": "20220921T073208", "authors": ["MarketBeat News"], "summary": "Research analysts at StockNews.com started coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research report issued on Wednesday. The brokerage set a \"hold\" rating on the stock. Several other equities research analysts have also issued reports on the company.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999186"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.147014, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.853856", "ticker_sentiment_score": "0.252456", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ROKU", "relevance_score": "0.082677", "ticker_sentiment_score": "-0.010302", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUTH", "relevance_score": "0.082677", "ticker_sentiment_score": "-0.010302", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.082677", "ticker_sentiment_score": "0.130668", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.164468", "ticker_sentiment_score": "0.173644", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on AC Immune  ( NASDAQ: ACIU ) ", "url": "https://beststocks.com/stocknews-com-begins-coverage-on-ac-immune-nasdaq/", "time_published": "20220913T194507", "authors": ["Yasmim Mendon\u00e7a"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of AC Immune ( NASDAQ: ACIU ) in a report released Monday. The brokerage set a \"hold\" rating on the stock. ACIU has been the subject of several other research reports.", "banner_image": "https://beststocks.com/wp-content/uploads/2022/06/Best-Stocks-To-Buy-Now-June-13-2022.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "beststocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.232529, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.942203", "ticker_sentiment_score": "0.402503", "ticker_sentiment_label": "Bullish"}, {"ticker": "MRNJ", "relevance_score": "0.09439", "ticker_sentiment_score": "0.191081", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.187463", "ticker_sentiment_score": "0.267914", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.etfdailynews.com/2022/09/12/stocknews-com-begins-coverage-on-ac-immune-nasdaqaciu-2/", "time_published": "20220912T061642", "authors": ["MarketBeat News"], "summary": "Equities researchers at StockNews.com initiated coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research note issued on Monday. The firm set a \"hold\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.227588, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.912398", "ticker_sentiment_score": "0.391374", "ticker_sentiment_label": "Bullish"}, {"ticker": "DG", "relevance_score": "0.085022", "ticker_sentiment_score": "0.00309", "ticker_sentiment_label": "Neutral"}, {"ticker": "EA", "relevance_score": "0.085022", "ticker_sentiment_score": "0.00309", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.085022", "ticker_sentiment_score": "0.211121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.169081", "ticker_sentiment_score": "0.280392", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://reporter.am/2022/09/12/stocknews-com-begins-coverage-on-ac-immune-nasdaqaciu.html", "time_published": "20220912T061641", "authors": ["AM Reporter Staff"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a report released on Monday. The brokerage set a \"hold\" rating on the stock. ACIU has been the subject of a number of other research reports.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.201473, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.912398", "ticker_sentiment_score": "0.348817", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DG", "relevance_score": "0.085022", "ticker_sentiment_score": "0.00309", "ticker_sentiment_label": "Neutral"}, {"ticker": "EA", "relevance_score": "0.085022", "ticker_sentiment_score": "0.00309", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.085022", "ticker_sentiment_score": "0.186876", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.169081", "ticker_sentiment_score": "0.249789", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Receives New Coverage from Analysts at StockNews.com", "url": "https://reporter.am/2022/09/05/ac-immune-nasdaqaciu-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20220905T075041", "authors": ["AM Reporter Staff"], "summary": "StockNews.com began coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the stock. Other equities analysts have also recently issued reports about the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.274311, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.888189", "ticker_sentiment_score": "0.460079", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.167904", "ticker_sentiment_score": "0.31326", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NKE", "relevance_score": "0.084423", "ticker_sentiment_score": "0.007179", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.084423", "ticker_sentiment_score": "0.236402", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.167904", "ticker_sentiment_score": "0.31326", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.etfdailynews.com/2022/09/04/stocknews-com-begins-coverage-on-ac-immune-nasdaqaciu/", "time_published": "20220904T060850", "authors": ["MarketBeat News"], "summary": "Equities researchers at StockNews.com assumed coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a report issued on Sunday. The firm set a \"sell\" rating on the stock. ACIU has been the topic of a number of other reports.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.216985, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.935372", "ticker_sentiment_score": "0.37673", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.172097", "ticker_sentiment_score": "0.234821", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NKE", "relevance_score": "0.086556", "ticker_sentiment_score": "0.00721", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.086556", "ticker_sentiment_score": "0.173423", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.172097", "ticker_sentiment_score": "0.234821", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Receives a Grant from The Michael J. Fox Foundation for Continued Development of Parkinson's Disease Diagnostic Imaging Agent", "url": "https://www.globenewswire.com/news-release/2022/09/01/2508481/0/en/AC-Immune-Receives-a-Grant-from-The-Michael-J-Fox-Foundation-for-Continued-Development-of-Parkinson-s-Disease-Diagnostic-Imaging-Agent.html", "time_published": "20220901T120000", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Sept. 01, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that The Michael J. Fox Foundation for Parkinson's Research ( MJFF ) awarded the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.273937, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.306113", "ticker_sentiment_score": "0.236606", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Initiates Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://reporter.am/2022/08/29/stocknews-com-initiates-coverage-on-ac-immune-nasdaqaciu.html", "time_published": "20220829T055842", "authors": ["AM Reporter Staff"], "summary": "Stock analysts at StockNews.com initiated coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research report issued to clients and investors on Saturday. The brokerage set a \"sell\" rating on the stock. A number of other equities research analysts also recently weighed in on the ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.29191, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.874135", "ticker_sentiment_score": "0.482681", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.16171", "ticker_sentiment_score": "0.333522", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.081276", "ticker_sentiment_score": "0.061152", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.081276", "ticker_sentiment_score": "0.256624", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.16171", "ticker_sentiment_score": "0.333522", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune KOL Webinar on the Potential Benefits of Vaccines for Alzheimer's and Parkinson's Diseases", "url": "https://www.globenewswire.com/news-release/2022/08/24/2504137/0/en/AC-Immune-KOL-Webinar-on-the-Potential-Benefits-of-Vaccines-for-Alzheimer-s-and-Parkinson-s-Diseases.html", "time_published": "20220824T200500", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Aug. 24, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( Nasdaq: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today hosted key opinion leader ( KOL ) Cynthia A.", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.250341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.399053", "ticker_sentiment_score": "0.21515", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket", "url": "https://www.benzinga.com/news/22/08/28597728/why-zoom-video-is-trading-lower-by-11-here-are-28-stocks-moving-premarket", "time_published": "20220823T113633", "authors": ["Lisa Levin"], "summary": "Quotient Limited QTNT shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. Aerie Pharmaceuticals, Inc. AERI shares rose 34.5% to $15.00 in pre-market trading. Alcon AG ALC agreed to acquire Aerie Pharmaceuticals for $15.25 per share, valuing Aerie at ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/23/image-zoom_video.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.95865"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.818451"}], "overall_sentiment_score": 0.033929, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DRUG", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.043101", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERI", "relevance_score": "0.121241", "ticker_sentiment_score": "0.319064", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLRB", "relevance_score": "0.121241", "ticker_sentiment_score": "-0.043874", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.121241", "ticker_sentiment_score": "0.141157", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAAS", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.011363", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.121241", "ticker_sentiment_score": "-0.112174", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.081001", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.121241", "ticker_sentiment_score": "0.170802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CHEK", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.279572", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KRBP", "relevance_score": "0.121241", "ticker_sentiment_score": "0.120904", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZ", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.315703", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PANW", "relevance_score": "0.040553", "ticker_sentiment_score": "0.103761", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.081001", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.121241", "ticker_sentiment_score": "0.033103", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.170471", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ASRT", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.010388", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRIN", "relevance_score": "0.081001", "ticker_sentiment_score": "0.204374", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EQOS", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.265132", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PIK", "relevance_score": "0.121241", "ticker_sentiment_score": "-0.148114", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.121241", "ticker_sentiment_score": "-0.098914", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.081001", "ticker_sentiment_score": "0.138684", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTL", "relevance_score": "0.121241", "ticker_sentiment_score": "-0.179856", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALC", "relevance_score": "0.081001", "ticker_sentiment_score": "0.285763", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GCT", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.323966", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VS", "relevance_score": "0.081001", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.081001", "ticker_sentiment_score": "-0.192038", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "StockNews.com Initiates Coverage on AC Immune  ( NASDAQ:ACIU ) ", "url": "https://www.etfdailynews.com/2022/08/19/stocknews-com-initiates-coverage-on-ac-immune-nasdaqaciu-2/", "time_published": "20220819T060848", "authors": ["MarketBeat News"], "summary": "Equities researchers at StockNews.com assumed coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a report issued on Friday. The brokerage set a \"sell\" rating on the stock. Other equities analysts have also recently issued reports about the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.280969, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.88183", "ticker_sentiment_score": "0.469001", "ticker_sentiment_label": "Bullish"}, {"ticker": "COST", "relevance_score": "0.082963", "ticker_sentiment_score": "0.050453", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.082963", "ticker_sentiment_score": "0.050453", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.082963", "ticker_sentiment_score": "0.236103", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.165031", "ticker_sentiment_score": "0.309274", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BJ", "relevance_score": "0.082963", "ticker_sentiment_score": "0.050453", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRRM", "relevance_score": "0.082963", "ticker_sentiment_score": "0.050453", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Now Covered by StockNews.com", "url": "https://reporter.am/2022/08/13/ac-immune-nasdaqaciu-now-covered-by-stocknews-com.html", "time_published": "20220813T085241", "authors": ["AM Reporter Staff"], "summary": "StockNews.com assumed coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research report released on Wednesday. The firm issued a sell rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.189968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.913524", "ticker_sentiment_score": "0.330223", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.085324", "ticker_sentiment_score": "0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.085324", "ticker_sentiment_score": "0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.085324", "ticker_sentiment_score": "0.178662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.169676", "ticker_sentiment_score": "0.239331", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2022/08/10/ac-immune-nasdaqaciu-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20220810T061646", "authors": ["admin"], "summary": "Equities researchers at StockNews.com assumed coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research note issued on Wednesday. The brokerage set a \"sell\" rating on the stock. Several other equities research analysts also recently commented on the company.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.250532, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.883106", "ticker_sentiment_score": "0.422947", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.165598", "ticker_sentiment_score": "0.231911", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.083251", "ticker_sentiment_score": "0.13349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.083251", "ticker_sentiment_score": "0.13349", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.083251", "ticker_sentiment_score": "0.174335", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Detailed Data From the Phase II Crenezumab Alzheimer's Prevention Initiative Study in Autosomal Dominant Alzheimer's Disease Presented at AAIC", "url": "https://www.globenewswire.com/news-release/2022/08/02/2490659/0/en/Detailed-Data-From-the-Phase-II-Crenezumab-Alzheimer-s-Prevention-Initiative-Study-in-Autosomal-Dominant-Alzheimer-s-Disease-Presented-at-AAIC.html", "time_published": "20220802T150000", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, Aug. 02, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( Nasdaq: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that its partners presented the first quantitative data from the Alzheimer's ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.12707, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.225473", "ticker_sentiment_score": "0.115392", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.284578", "ticker_sentiment_score": "0.182976", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Detailed Data From the Phase II Crenezumab Alzheimer's Prevention Initiative Study in Autosomal Dominant Alzheimer's Disease Presented at AAIC", "url": "https://www.benzinga.com/pressreleases/22/08/g28313246/detailed-data-from-the-phase-ii-crenezumab-alzheimers-prevention-initiative-study-in-autosomal-dom", "time_published": "20220802T150000", "authors": ["Globe Newswire"], "summary": "Crenezumab was safe and well tolerated with no cases of ARIA-E observed during the up to eight-year study As previously reported, numerical differences favoring crenezumab over placebo were confirmed across the co-primary, multiple secondary and exploratory endpoints, none statistically significant", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.119886, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.217568", "ticker_sentiment_score": "0.113819", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.293506", "ticker_sentiment_score": "0.176809", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study", "url": "https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax", "time_published": "20220802T122759", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: Allarity Therapeutics Inc ALLR said it would refocus its oncology pipeline strategy away from the development of monotherapies toward combination therapies.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/02/biotech4.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.093866, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KRYS", "relevance_score": "0.105372", "ticker_sentiment_score": "0.112291", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.105372", "ticker_sentiment_score": "0.12207", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYTM", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.157483", "ticker_sentiment_score": "0.079368", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.157483", "ticker_sentiment_score": "0.009685", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.157483", "ticker_sentiment_score": "0.03904", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESPR", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXLA", "relevance_score": "0.105372", "ticker_sentiment_score": "0.029933", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLTF", "relevance_score": "0.105372", "ticker_sentiment_score": "0.084091", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INCY", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIGL", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HALO", "relevance_score": "0.105372", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( ACIU )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/1959431/ac-immune-aciu-reports-q2-loss-lags-revenue-estimates", "time_published": "20220728T124511", "authors": ["Zacks Investment Research"], "summary": "AC Immune (ACIU) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default205.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.108013, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.411176", "ticker_sentiment_score": "0.039262", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.213048", "ticker_sentiment_score": "0.102199", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune  ( NASDAQ:ACIU )  Receives New Coverage from Analysts at StockNews.com", "url": "https://reporter.am/2022/07/28/ac-immune-nasdaqaciu-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20220728T083441", "authors": ["AM Reporter Staff"], "summary": "StockNews.com assumed coverage on shares of AC Immune ( NASDAQ:ACIU - Get Rating ) in a research note released on Wednesday. The firm issued a sell rating on the stock. A number of other research analysts have also commented on the company.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/ac-immune-ltd-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.231872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.940212", "ticker_sentiment_score": "0.401643", "ticker_sentiment_label": "Bullish"}, {"ticker": "BLK", "relevance_score": "0.18602", "ticker_sentiment_score": "0.240354", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.093653", "ticker_sentiment_score": "-0.038558", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNJ", "relevance_score": "0.093653", "ticker_sentiment_score": "0.171645", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AC Immune Announces Upcoming Presentations at the Alzheimer's Association International Conference", "url": "https://www.globenewswire.com/news-release/2022/07/22/2484356/0/en/AC-Immune-Announces-Upcoming-Presentations-at-the-Alzheimer-s-Association-International-Conference.html", "time_published": "20220722T113000", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, July 22, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced 10 upcoming presentations that will be delivered at the Alzheimer's ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.091529, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.377142", "ticker_sentiment_score": "0.096209", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.097854", "ticker_sentiment_score": "0.028666", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Holds Annual General Meeting of Shareholders", "url": "https://www.globenewswire.com/news-release/2022/06/24/2469015/0/en/AC-Immune-Holds-Annual-General-Meeting-of-Shareholders.html", "time_published": "20220624T203000", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, June 24, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the Company held its Annual General Meeting per Swiss law.", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.082449, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.422402", "ticker_sentiment_score": "0.082449", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.044411", "ticker_sentiment_score": "0.006403", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna", "url": "https://www.zacks.com/stock/news/1940866/the-zacks-analyst-blog-highlights-lilly-merck-roche-pfizer-and-moderna", "time_published": "20220620T092400", "authors": ["Zacks Investment Research"], "summary": "Lilly, Merck, Roche, Pfizer and Moderna have been included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/20/2483.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": -0.106828, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.026523", "ticker_sentiment_score": "-0.035452", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.026523", "ticker_sentiment_score": "-0.035452", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.105801", "ticker_sentiment_score": "-0.007806", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.334425", "ticker_sentiment_score": "-0.080136", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.132033", "ticker_sentiment_score": "-0.02385", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More", "url": "https://www.zacks.com/stock/news/1940269/pharma-stock-roundup-fda-panel-nod-for-pfe-mrna-young-kids-covid-jabs-more", "time_published": "20220617T123700", "authors": ["Zacks Investment Research"], "summary": "FDA panel recommends the use of PFE, MRNA COVID vaccine in kids under five. LLY's Alzheimer's candidate fails to show clinical benefit in study. FDA approves expanded use of LLY's Olumiant.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": -0.097297, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.039058", "ticker_sentiment_score": "-0.042264", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.039058", "ticker_sentiment_score": "-0.042264", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.116801", "ticker_sentiment_score": "-0.027661", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.443239", "ticker_sentiment_score": "-0.118991", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.193434", "ticker_sentiment_score": "-0.015649", "ticker_sentiment_label": "Neutral"}]}, {"title": "Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen", "url": "https://www.zacks.com/stock/news/1940270/roche-alzheimers-candidate-failure-hurts-lilly-biogen", "time_published": "20220617T123100", "authors": ["Zacks Investment Research"], "summary": "Eli Lilly (LLY) and Biogen's (BIIB) Alzheimer's candidates, anti-amyloid beta antibodies, are in late-stage development and are expected to be launched in a few months.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": -0.042749, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.160633", "ticker_sentiment_score": "-0.021441", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.05387", "ticker_sentiment_score": "-0.016891", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.160633", "ticker_sentiment_score": "0.004409", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.064442", "ticker_sentiment_label": "Neutral"}]}, {"title": "Roche's experimental Alzheimer's drug crenezumab fails to prevent cognitive decline in people | The Financial Express", "url": "https://www.financialexpress.com/healthcare/pharma-healthcare/roches-experimental-alzheimers-drug-crenezumab-fails-to-prevent-cognitive-decline-in-people/2564179/", "time_published": "20220617T084432", "authors": [], "summary": "The Swiss drugmaker had hoped to prove crenezumab, which is designed to block beta-amyloid, could prevent the memory-robbing disease if given before symptoms emerged.", "banner_image": "https://www.financialexpress.com/wp-content/uploads/2022/06/thermometer-gb80a1464a_1920-1.jpg", "source": "The Financial Express", "category_within_source": "n/a", "source_domain": "www.financialexpress.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.133745, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.106164", "ticker_sentiment_score": "-0.000128", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.106164", "ticker_sentiment_score": "-0.436942", "ticker_sentiment_label": "Bearish"}]}, {"title": "Mid-Afternoon Market Update: Dow Dips 900 Points; AC Immune Shares Slide", "url": "https://www.benzinga.com/news/earnings/22/06/27751137/mid-afternoon-market-update-dow-dips-900-points-ac-immune-shares-slide", "time_published": "20220616T190012", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower toward the end of trading, after the Federal Reserve raised fed funds rates by 0.75% to a new target range of between 1.5% and 1.75% on Wednesday. The Dow traded down 2.97% to 29,756.66 while the NASDAQ fell 4.73% to 10,573.75. The S&P also fell, dropping, 3.87% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/16/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.042629, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.077455", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.208884", "ticker_sentiment_score": "0.005103", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.208884", "ticker_sentiment_score": "0.008009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRG", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.042407", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.011561", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.140157", "ticker_sentiment_score": "0.056128", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.140157", "ticker_sentiment_score": "0.008596", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLX", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.011561", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.070352", "ticker_sentiment_score": "0.008596", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mid-Day Market Update: Dow Tumbles 700 points; Advent Technologies Shares Spike Higher", "url": "https://www.benzinga.com/news/earnings/22/06/27747497/mid-day-market-update-dow-tumbles-700-points-advent-technologies-shares-spike-higher", "time_published": "20220616T164507", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower midway through trading, after the Federal Reserve raised fed funds rates by 0.75% to a new target range of between 1.5% and 1.75% on Wednesday. The Dow traded down 2.33% to 29,950.08 while the NASDAQ fell 3.87% to 10,669.74. The S&P also fell, dropping, 3.18% to 3,669.08.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/16/mid-day-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.033618, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.139064", "ticker_sentiment_score": "-0.027103", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.207275", "ticker_sentiment_score": "0.007269", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.207275", "ticker_sentiment_score": "0.008997", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRID", "relevance_score": "0.139064", "ticker_sentiment_score": "-0.026024", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRG", "relevance_score": "0.139064", "ticker_sentiment_score": "-0.046291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.139064", "ticker_sentiment_score": "0.048408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.139064", "ticker_sentiment_score": "0.007959", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.139064", "ticker_sentiment_score": "-0.026024", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.069798", "ticker_sentiment_score": "0.007959", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK", "url": "https://www.benzinga.com/general/biotech/22/06/27737919/the-daily-biotech-pulse-roches-alzheimers-drug-fails-advisors-back-pfizer-moderna-shots-for-young", "time_published": "20220616T140943", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: The FDA's Vaccines and Related Biological Products Advisory Committee voted in favor of amending the emergency use authorization ( EUA ) for Moderna Inc's MRNA and Pfizer Inc PFE/BioNTech SE BNTX COVID-19 vaccines ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/16/syringe-ge28143bc6_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.017318, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RPTX", "relevance_score": "0.098719", "ticker_sentiment_score": "4.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.195933", "ticker_sentiment_score": "-0.004117", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYTM", "relevance_score": "0.098719", "ticker_sentiment_score": "0.040821", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.098719", "ticker_sentiment_score": "-0.002903", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.243522", "ticker_sentiment_score": "0.118234", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.098719", "ticker_sentiment_score": "-0.002903", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.098719", "ticker_sentiment_score": "0.005952", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.098719", "ticker_sentiment_score": "0.015425", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.098719", "ticker_sentiment_score": "0.058626", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPTI", "relevance_score": "0.098719", "ticker_sentiment_score": "0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXEL", "relevance_score": "0.147607", "ticker_sentiment_score": "0.003742", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.098719", "ticker_sentiment_score": "0.009211", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.195933", "ticker_sentiment_score": "0.001107", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.147607", "ticker_sentiment_score": "0.000232", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mid-Morning Market Update: Markets Open Lower; US Jobless Claims Fall To 229,000", "url": "https://www.benzinga.com/news/earnings/22/06/27740742/mid-morning-market-update-markets-open-lower-us-jobless-claims-fall-to-229-000", "time_published": "20220616T135428", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower this morning, after the Federal Reserve raised interest rates by 0.75% on Wednesday. Following the market opening Thursday, the Dow traded down 2.53% to 29,891.78 while the NASDAQ fell 2.93% to 10,773.95. The S&P also fell, dropping, 2.85% to 3,681.85.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/16/mid-morning-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.050382, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.146514", "ticker_sentiment_score": "-0.024087", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.218226", "ticker_sentiment_score": "0.008393", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRG", "relevance_score": "0.146514", "ticker_sentiment_score": "-0.086424", "ticker_sentiment_label": "Neutral"}, {"ticker": "CANG", "relevance_score": "0.146514", "ticker_sentiment_score": "0.119469", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBIX", "relevance_score": "0.146514", "ticker_sentiment_score": "0.000882", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.146514", "ticker_sentiment_score": "-0.007643", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.146514", "ticker_sentiment_score": "0.00798", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.146514", "ticker_sentiment_score": "-0.007643", "ticker_sentiment_label": "Neutral"}]}, {"title": "Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients", "url": "https://www.benzinga.com/general/biotech/22/06/27736937/roches-crenezumab-fails-to-show-benefit-in-sub-set-of-alzheimers-patients", "time_published": "20220616T122040", "authors": ["Vandana Singh"], "summary": "Roche Holdings AG RHHBY said its Alzheimer's medicine crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation that causes early-onset disease.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/16/aapharma_3.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.053893, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.399416", "ticker_sentiment_score": "0.013257", "ticker_sentiment_label": "Neutral"}]}, {"title": "Roche provides update on Alzheimer's Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer's disease", "url": "https://www.globenewswire.com/news-release/2022/06/16/2463591/0/en/Roche-provides-update-on-Alzheimer-s-Prevention-Initiative-study-evaluating-crenezumab-in-autosomal-dominant-Alzheimer-s-disease.html", "time_published": "20220616T050000", "authors": ["F. Hoffmann-La Roche Ltd"], "summary": "Basel, 16 June 2022 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) , together with Banner Alzheimer's Institute, today announced results from the Alzheimer's Prevention Initiative ( API ) Autosomal Dominant Alzheimer's Disease ( ADAD ) Colombia Trial.", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/696b7c85-2d23-4f5e-a77b-8c6b2fa45d47?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.069856, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.044626", "ticker_sentiment_score": "0.027687", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.241749", "ticker_sentiment_score": "0.083466", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHGCF", "relevance_score": "0.022322", "ticker_sentiment_score": "0.018638", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Provides Update on Alzheimer's Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer's Disease", "url": "https://www.globenewswire.com/news-release/2022/06/16/2463588/0/en/AC-Immune-Provides-Update-on-Alzheimer-s-Prevention-Initiative-Study-Evaluating-Crenezumab-in-Autosomal-Dominant-Alzheimer-s-Disease.html", "time_published": "20220616T050000", "authors": ["AC Immune SA"], "summary": "Crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer's disease ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.045603, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.224466", "ticker_sentiment_score": "0.051455", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.202535", "ticker_sentiment_score": "0.032129", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the 2022 Jefferies Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/05/g27469334/ac-immune-to-present-at-the-2022-jefferies-healthcare-conference", "time_published": "20220531T113000", "authors": ["Globe Newswire"], "summary": "LAUSANNE, Switzerland, May 31, 2022 ( GLOBE NEWSWIRE ) -- AC Immune SA ( NASDAQ:ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor m", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.071747, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.421837", "ticker_sentiment_score": "0.082562", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article", "time_published": "20220511T162815", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 807 companies reached new 52-week lows.\nThings to Consider About Today's 52-Week Lows:\nAmazon.com  ( NASDAQ:AMZN )  was the largest company by market cap to set a new 52-week low.\nGames & Esports  ( NASDAQ:GEEXW )  was the smallest company by market cap to set a new 52-week low.\nView  ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8443.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.026939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00124", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.036124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003313", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000149", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002042", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000991", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVID", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.370079", "ticker_sentiment_label": "Bearish"}, {"ticker": "SCOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007315", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008312", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004985", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.006905", "ticker_sentiment_score": "0.046669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006647", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028036", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.006905", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.435265", "ticker_sentiment_label": "Bearish"}, {"ticker": "AZRE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007661", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010696", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.569147", "ticker_sentiment_label": "Bearish"}, {"ticker": "VITL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01899", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002672", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006481", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000956", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.030942", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006892", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006208", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027974", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTER", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001811", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004785", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003781", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033286", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.032128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007747", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014035", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.026043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002584", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030553", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.102966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.018006", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.083313", "ticker_sentiment_label": "Neutral"}, {"ticker": "DH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002316", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01368", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.114162", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001387", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002708", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.041261", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001014", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029453", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.503669", "ticker_sentiment_label": "Bearish"}, {"ticker": "ABEO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010621", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.044931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057114", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025648", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.442405", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEJU", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNGX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00338", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010371", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFMD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033985", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008683", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001147", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.029975", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031721", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006969", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005509", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002347", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.026602", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000946", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003622", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001759", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002882", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01973", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002991", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015008", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006371", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004448", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003716", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005806", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032353", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.274715", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VERI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006905", "ticker_sentiment_score": "-7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NABL", "relevance_score": "0.01381", "ticker_sentiment_score": "-0.065212", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.035094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.017236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004494", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005494", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.027744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.380308", "ticker_sentiment_label": "Bearish"}, {"ticker": "YTEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020472", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03797", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.199176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SBTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008026", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00697", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.284624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033445", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.020713", "ticker_sentiment_score": "-0.00707", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001403", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029958", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053345", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.395079", "ticker_sentiment_label": "Bearish"}, {"ticker": "IONQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000885", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.057018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013737", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002159", "ticker_sentiment_label": "Neutral"}, {"ticker": "KD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000517", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00385", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAMOD", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.011888", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.201653", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014804", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.01381", "ticker_sentiment_score": "0.000537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.034535", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002931", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00339", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014879", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005779", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02828", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008229", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009155", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04243", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.358226", "ticker_sentiment_label": "Bearish"}, {"ticker": "TARA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00569", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006707", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.360118", "ticker_sentiment_label": "Bearish"}, {"ticker": "LAW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00929", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020967", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004281", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.006905", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003453", "ticker_sentiment_score": "0.131467", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005482", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029909", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020147", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005557", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003453", "ticker_sentiment_score": "0.008905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392024", "ticker_sentiment_label": "Bearish"}, {"ticker": "SMMT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010153", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011101", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000751", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019578", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015302", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01087", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003034", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007657", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006713", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.018388", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003455", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.066657", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.219042", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009159", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031329", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003443", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "OM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.03401", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021611", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033908", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02022", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005958", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004778", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRPX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.042368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006722", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006844", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005504", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.003453", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.019138", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNFT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007461", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTOS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004453", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001344", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007561", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006905", "ticker_sentiment_score": "4.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013924", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTIX", "relevance_score": "0.006905", "ticker_sentiment_score": "5.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029837", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009979", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSFE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.066369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017007", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006269", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02275", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002829", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.354538", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00193", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.259224", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MIR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004637", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.074059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004011", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.024874", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001667", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012462", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003477", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005184", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.010357", "ticker_sentiment_score": "0.001464", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "KGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012165", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004396", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019067", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000834", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003971", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001533", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RIOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02771", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.083853", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.031917", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.041747", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEPG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007498", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.029087", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011377", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.298818", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PZZA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001777", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009522", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.004382", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004749", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001507", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008075", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009289", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392113", "ticker_sentiment_label": "Bearish"}, {"ticker": "FBIO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002737", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.028695", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.039738", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011907", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009098", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002578", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021993", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007203", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.362989", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCTY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006714", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014569", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OUST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.294166", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORMP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000939", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007505", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.374918", "ticker_sentiment_label": "Bearish"}, {"ticker": "SFIX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.045373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004172", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.285345", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HYPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001889", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04092", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEWR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010603", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02631", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001556", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0152", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009431", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007666", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002913", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005884", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.059974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004692", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007552", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.006905", "ticker_sentiment_score": "3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000267", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.30025", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TNYA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.021404", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011834", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005064", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.280779", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FVRR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.332594", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ELAN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005139", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007599", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.303151", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EAR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.515459", "ticker_sentiment_label": "Bearish"}, {"ticker": "ZS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002864", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLKB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.038783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009183", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00365", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003406", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.044645", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRZE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIDM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033794", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TELA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICHR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019517", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015065", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.185111", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00253", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003239", "ticker_sentiment_label": "Neutral"}, {"ticker": "POLA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.473604", "ticker_sentiment_label": "Bearish"}, {"ticker": "BRSYF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.009217", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.065524", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003907", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNSO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003669", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010652", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005464", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006496", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012732", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009064", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009894", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.017179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIBS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.025121", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019209", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.542631", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOEV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006919", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.46795", "ticker_sentiment_label": "Bearish"}, {"ticker": "TACT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005671", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGPPF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.001751", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.303128", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HLF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030714", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01328", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009974", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.062454", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006434", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017918", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002596", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003579", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005085", "ticker_sentiment_label": "Neutral"}, {"ticker": "HURC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025491", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004826", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009901", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003009", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.079266", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007781", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.05939", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRSO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NMR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:AMPL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTX", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00696", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:EOT", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.000625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SLS", "relevance_score": "0.003453", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:TRX", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.198959", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "AC Immune's Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology", "url": "https://www.globenewswire.com/news-release/2022/05/09/2438842/0/en/AC-Immune-s-Anti-Abeta-Vaccine-Results-from-Phase-1b-Study-in-Down-Syndrome-Published-in-JAMA-Neurology.html", "time_published": "20220509T150000", "authors": ["AC Immune SA"], "summary": "First study of an anti-Abeta vaccine in people living with Down syndrome  ( DS )", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.060685, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.284714", "ticker_sentiment_score": "0.060685", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article", "time_published": "20220506T160650", "authors": ["Benzinga Insights"], "summary": "On Friday, 1043 companies hit new 52-week lows.\nInteresting Points From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Amazon.com  ( NASDAQ:AMZN ) .\nThe smallest company by market cap to set a new 52-week low was Digital Brands Group  ( NASDAQ:DBGI ) .\nDigital B", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8140.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018654, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVIR", "relevance_score": "0.005467", "ticker_sentiment_score": "8e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014739", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007715", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001369", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002362", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001586", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007408", "ticker_sentiment_label": "Neutral"}, {"ticker": "XXII", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009055", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004464", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004759", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01506", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011593", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001593", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006114", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.474612", "ticker_sentiment_label": "Bearish"}, {"ticker": "QTWO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012224", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.024001", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.002733", "ticker_sentiment_score": "0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011692", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001746", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYZN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001565", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001468", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007395", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.002733", "ticker_sentiment_score": "0.002022", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00383", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001562", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.129948", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRIX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006773", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004773", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001338", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034278", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000513", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040341", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012428", "ticker_sentiment_label": "Neutral"}, {"ticker": "EJH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001005", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.036375", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.023456", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000242", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006596", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009028", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00231", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008036", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGND", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.01088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001986", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002803", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.024212", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014222", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001119", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.005467", "ticker_sentiment_score": "0.052688", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.007807", "ticker_sentiment_label": "Neutral"}, {"ticker": "CECE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005194", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013762", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005592", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005844", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009328", "ticker_sentiment_label": "Neutral"}, {"ticker": "USIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012453", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004647", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004948", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.024503", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000807", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00089", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005297", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEXAF", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRDN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013388", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.23749", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BKSY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002256", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003607", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011872", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRT", "relevance_score": "0.005467", "ticker_sentiment_score": "-8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013198", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDUS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020137", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020564", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005341", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01126", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00157", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004358", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005188", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001055", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.311797", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMZN", "relevance_score": "0.010933", "ticker_sentiment_score": "0.03713", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLPX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000599", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009637", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003057", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017429", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014996", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.029089", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003114", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.0008", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.016288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014144", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008835", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022839", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002688", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01261", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCTI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005777", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017979", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031719", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001659", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00094", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.080114", "ticker_sentiment_label": "Neutral"}, {"ticker": "EA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012633", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000665", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001816", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000255", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.236976", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MTEM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010779", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDWR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003915", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.04504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003646", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005439", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.034088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPLK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015781", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007337", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018307", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVGW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013234", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.035619", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLSP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000154", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006624", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015607", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000819", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001435", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001422", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013934", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.268097", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012076", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.013666", "ticker_sentiment_score": "0.006812", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009472", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.07076", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001962", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.273034", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLGC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016342", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006369", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.005467", "ticker_sentiment_score": "-6.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017042", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002798", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005366", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004709", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.058432", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003189", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027782", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013102", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010952", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.226453", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AVPT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01004", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008074", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.061768", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040384", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001721", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00805", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034103", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012549", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01047", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.199823", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GTH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006255", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006344", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.027141", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000398", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022958", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006198", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.044346", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014461", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTEA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.251893", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EGHT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.076938", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006349", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002389", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.409825", "ticker_sentiment_label": "Bearish"}, {"ticker": "SLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000645", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004714", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001534", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00345", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001229", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016298", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008228", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.048692", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009323", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005174", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006195", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.005467", "ticker_sentiment_score": "2e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.084388", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.094167", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000887", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009445", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000875", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003603", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAMF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0292", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001993", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.119529", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000954", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.04525", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002805", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033035", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007984", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000961", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012775", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.025156", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.03279", "ticker_sentiment_score": "-0.036069", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000607", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011983", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000361", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.002733", "ticker_sentiment_score": "0.006114", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005723", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015929", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002884", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAFN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.043899", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008608", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007081", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.02263", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002717", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.258621", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00397", "ticker_sentiment_label": "Neutral"}, {"ticker": "OFIX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002062", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02661", "ticker_sentiment_label": "Neutral"}, {"ticker": "INKT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011193", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013174", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006793", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006695", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004219", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006041", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004581", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005917", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002869", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00512", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013203", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007206", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003064", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000239", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.265921", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "USX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000322", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMDA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.043956", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002616", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003623", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014188", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040211", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.027933", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPCE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002119", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004457", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007082", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008507", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004771", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000108", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004933", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008819", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.03789", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01756", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSII", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000825", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.698832", "ticker_sentiment_label": "Bearish"}, {"ticker": "DTIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01385", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPSC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.002733", "ticker_sentiment_score": "0.001371", "ticker_sentiment_label": "Neutral"}, {"ticker": "AME", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012928", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006004", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTZ", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002859", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030168", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000206", "ticker_sentiment_label": "Neutral"}, {"ticker": "EKSO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003713", "ticker_sentiment_label": "Neutral"}, {"ticker": "MQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015197", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003802", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011322", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.088737", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002271", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.002733", "ticker_sentiment_score": "0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.032558", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010496", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016762", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00505", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.126406", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004043", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.231438", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005503", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003601", "ticker_sentiment_label": "Neutral"}, {"ticker": "NH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002642", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006202", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016006", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMCX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.322204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006243", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001254", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004234", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRSH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001954", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-1.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.057756", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.314355", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TTC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014229", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00678", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005629", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.11505", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003534", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.031284", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.085718", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006355", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007852", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001378", "ticker_sentiment_label": "Neutral"}, {"ticker": "LANC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.039126", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001517", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020486", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010664", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMED", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00714", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007612", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.056186", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.232694", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017063", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004039", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005847", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018945", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002418", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.024422", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011084", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCPC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008599", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001835", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAYW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001919", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007904", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.044445", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007168", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000657", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007032", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009564", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004855", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004686", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.013666", "ticker_sentiment_score": "0.045786", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLTO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008852", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUMZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007579", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003623", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.101736", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005012", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.005467", "ticker_sentiment_score": "7.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02523", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011803", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003633", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011031", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.017866", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKLF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001304", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011765", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002028", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.005467", "ticker_sentiment_score": "-3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVRO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.176704", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.019739", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.129262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMBM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.016593", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022574", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.043663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002505", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.182188", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GMVD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002648", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003056", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012718", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000923", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012214", "ticker_sentiment_label": "Neutral"}, {"ticker": "RL", "relevance_score": "0.005467", "ticker_sentiment_score": "3.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01715", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010254", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNEY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.028703", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008803", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001075", "ticker_sentiment_label": "Neutral"}, {"ticker": "SVC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.048687", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006639", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002373", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLDP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.028201", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIAN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00265", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005483", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRGO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.306708", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PENN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004995", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001646", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006674", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.021491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.10492", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020113", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.050619", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006791", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010455", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.0063", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEAM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.181627", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TOUR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZEK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006728", "ticker_sentiment_label": "Neutral"}, {"ticker": "TU", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.039919", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031993", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.039985", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.036653", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.019148", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004549", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002594", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.0082", "ticker_sentiment_score": "0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000687", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.399338", "ticker_sentiment_label": "Bearish"}, {"ticker": "HBI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000129", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00448", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02444", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001127", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001434", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002927", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005529", "ticker_sentiment_label": "Neutral"}, {"ticker": "PZZA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.216241", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EWTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00763", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007568", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006633", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.082156", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000321", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.021783", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.029358", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015918", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.123083", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.014079", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007326", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.231255", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CZR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.046173", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.342782", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IEX", "relevance_score": "0.002733", "ticker_sentiment_score": "0.003273", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000512", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007898", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003474", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007337", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020501", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.20525", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RPAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001644", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004712", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.005467", "ticker_sentiment_score": "-8.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005839", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000117", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007389", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001608", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013813", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDGR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002045", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007048", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01293", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCTY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.05687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008196", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002175", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011886", "ticker_sentiment_label": "Neutral"}, {"ticker": "WATT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006975", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017878", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008648", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLVX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000955", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.002733", "ticker_sentiment_score": "0.002505", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.057288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01479", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.002733", "ticker_sentiment_score": "0.011809", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006237", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000276", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009272", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007028", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003805", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006874", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0073", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020156", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005603", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWKS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018675", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.23752", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TBBK", "relevance_score": "0.013666", "ticker_sentiment_score": "-0.002262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006014", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.020063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01275", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCYC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.336826", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AXDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010578", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002879", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.055874", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.082372", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.213356", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LOB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000114", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBSE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030308", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012338", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.025703", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007697", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004579", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027221", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001411", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007341", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030723", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020412", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000575", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010626", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002645", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELAN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.019388", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.240893", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APVO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000495", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005445", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.030796", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTEC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001647", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMIH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002191", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.045238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.038477", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.280251", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BLKB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.391783", "ticker_sentiment_label": "Bearish"}, {"ticker": "WEN", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.001309", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002166", "ticker_sentiment_label": "Neutral"}, {"ticker": "REPL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011409", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTGT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000715", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000289", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009802", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPGF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01843", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011116", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOUT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002942", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010036", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006359", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSWI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005483", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020431", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004394", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00472", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.05572", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011858", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.292269", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETSY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034284", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00684", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004989", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00026", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.219197", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CPRI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008358", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSKD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033578", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00735", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000205", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.178497", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "FROG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001322", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007702", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001374", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.279642", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADAP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015143", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011593", "ticker_sentiment_label": "Neutral"}, {"ticker": "UEIC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.028225", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVHI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004326", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003913", "ticker_sentiment_label": "Neutral"}, {"ticker": "LILA", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.001145", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.191057", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EDR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007616", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.053682", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.036612", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003554", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBKB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001143", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.015375", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007141", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000252", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008964", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTRP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012085", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001698", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012988", "ticker_sentiment_label": "Neutral"}, {"ticker": "JJSF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.05471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00683", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004935", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.126513", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000836", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033769", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012161", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006295", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002734", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011746", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002102", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASAN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018369", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011543", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.464763", "ticker_sentiment_label": "Bearish"}, {"ticker": "WIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004222", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000752", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.316405", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LTCH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002004", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003344", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.066118", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0198", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004344", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001654", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001238", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010854", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.006894", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014495", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011586", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030689", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEDS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011337", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013645", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004338", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRPT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.032635", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWBI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.287692", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGTX", "relevance_score": "0.005467", "ticker_sentiment_score": "6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010302", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014747", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.005467", "ticker_sentiment_score": "0.039922", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.002733", "ticker_sentiment_score": "0.009564", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alzheimer's Drugs Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis", "url": "https://www.benzinga.com/pressreleases/22/05/g27015849/alzheimers-drugs-market-size-2022-2028-industry-size-share-growth-trends-forecast-analysis", "time_published": "20220505T112802", "authors": ["Globe Newswire"], "summary": "Pune, India, May  05, 2022   ( GLOBE NEWSWIRE )  -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer's drugs which in turn is driving the global Alzheimer's drugs market, says Fortune Business Insights in a report, titled Alzheimer's Drugs Market Size , Share and Glob", "banner_image": "https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.056965, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.094167", "ticker_sentiment_score": "0.079608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.031454", "ticker_sentiment_score": "0.021912", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.031454", "ticker_sentiment_score": "0.021912", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article", "time_published": "20220428T193101", "authors": ["Benzinga Insights"], "summary": "During Thursday, 849 stocks hit new 52-week lows.\nAreas of Significance In Today's 52-Week Lows:\nJPMorgan Chase  ( NYSE:JPM )  was the largest company by market cap to set a new 52-week low.\nReshape Lifesciences  ( NASDAQ:RSLS )  was the smallest company by market cap to set a new 52-week low.\nSio G", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7522.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.021657, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AGLE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002281", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010868", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.051153", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.020002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001297", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001586", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.034523", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005054", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003889", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000308", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZFL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACCD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01882", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008662", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006733", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002203", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007303", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012398", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.019531", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYZN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001166", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011619", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002441", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003785", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.012869", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002878", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.09366", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.026358", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004437", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012377", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005977", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLIC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000659", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001762", "ticker_sentiment_label": "Neutral"}, {"ticker": "B", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.280809", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVEC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002518", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002847", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.053296", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.184467", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AGNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002529", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.02574", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012377", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013957", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007971", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.03367", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTG-P-A", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.00353", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNGR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008845", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.023679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014395", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002753", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006444", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.464253", "ticker_sentiment_label": "Bearish"}, {"ticker": "VLN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.035858", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.027313", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.00966", "ticker_sentiment_score": "0.031456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001412", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005658", "ticker_sentiment_label": "Neutral"}, {"ticker": "THR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.00644", "ticker_sentiment_score": "-8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005037", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.020067", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007729", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.031805", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002327", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008137", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.025595", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000959", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017589", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003678", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005154", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009037", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005288", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.068816", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005635", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000155", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008461", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005528", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006444", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQNS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.033398", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012047", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001089", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001825", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.358811", "ticker_sentiment_label": "Bearish"}, {"ticker": "TALK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002357", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001446", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006099", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017331", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004456", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002967", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "UVSP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.408395", "ticker_sentiment_label": "Bearish"}, {"ticker": "MEIP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00379", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005402", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002922", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002056", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006569", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002422", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.307504", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AKYA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005977", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.190274", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VXRT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012793", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003586", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015811", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011528", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000356", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00583", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008284", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002677", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007335", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016626", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLOW", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003946", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01674", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.051774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006995", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYRN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001235", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.016099", "ticker_sentiment_score": "0.000365", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00168", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014433", "ticker_sentiment_label": "Neutral"}, {"ticker": "YVR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012297", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006397", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001728", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005832", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.274058", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005263", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010016", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.313902", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JBLU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.0142", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.128943", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016135", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.088384", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000408", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007721", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005385", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.014783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005922", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010701", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022519", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015316", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007842", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005287", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004948", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.031777", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.040385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002522", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004033", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012589", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005658", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014061", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.057268", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010071", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003083", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011378", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007585", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.036257", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001596", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018017", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.0005", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005897", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008301", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.02132", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.047516", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001047", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000992", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007742", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.045056", "ticker_sentiment_score": "-0.039952", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004819", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004075", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019221", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003889", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000785", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036915", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004755", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.021416", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001461", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023262", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003233", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001071", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007419", "ticker_sentiment_label": "Neutral"}, {"ticker": "COO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010804", "ticker_sentiment_label": "Neutral"}, {"ticker": "JANX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001681", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00142", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010704", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007945", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004548", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003057", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001939", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014414", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.044631", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005078", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.058081", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00482", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000592", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017275", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008621", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.00644", "ticker_sentiment_score": "5.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003303", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00889", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.058715", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.00322", "ticker_sentiment_score": "0.009115", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001569", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012337", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005202", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004386", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001913", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWBI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004371", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017303", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005891", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00938", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010959", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016789", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01549", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021198", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000766", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.00322", "ticker_sentiment_score": "0.038901", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.00644", "ticker_sentiment_score": "0.064194", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.011992", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000203", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.035857", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00493", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.00644", "ticker_sentiment_score": "0.030028", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014657", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.011702", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022992", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXPE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003719", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010361", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.247008", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004395", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.000785", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015331", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.00644", "ticker_sentiment_score": "0.015207", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001779", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007614", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.2485", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HYFM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.303739", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003442", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.00644", "ticker_sentiment_score": "-6.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.011162", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018135", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013317", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRSH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006791", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001135", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00485", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007165", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005578", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPWH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.297525", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.308404", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EXPI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008762", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008116", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEAR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004224", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00141", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005985", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000164", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004364", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000157", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000309", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017341", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003922", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00708", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012733", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012832", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036996", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017498", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010161", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.050789", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "APM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.129275", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010264", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009655", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLTO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.039903", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001927", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002391", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.062391", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006279", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001177", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.24289", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIASP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.033144", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.024129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005125", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001545", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000655", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018191", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.260944", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EDIT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.185343", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HOVNP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.001198", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000532", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSIS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001848", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.034412", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012081", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002426", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.038823", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.03039", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005866", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006519", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.027821", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005082", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004159", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012641", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002503", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006289", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000852", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.289452", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004555", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTCR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002655", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABUS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.034847", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000574", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.023652", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018104", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.051778", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002389", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009245", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003323", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022809", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005711", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010312", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000688", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001735", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000362", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003686", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.035833", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.018451", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007251", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.047583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001743", "ticker_sentiment_label": "Neutral"}, {"ticker": "TT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004613", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZEK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002141", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.031966", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAHC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001708", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007752", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.058722", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009879", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005535", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.136158", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010107", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010125", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004479", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008591", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011976", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003862", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIOX", "relevance_score": "0.012879", "ticker_sentiment_score": "0.014893", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00645", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013867", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.042532", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012683", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004674", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.313368", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UIHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005697", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003396", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008654", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008734", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003688", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015215", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015197", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002305", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.232892", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01443", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011081", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.00966", "ticker_sentiment_score": "0.016109", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008519", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004443", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.483287", "ticker_sentiment_label": "Bearish"}, {"ticker": "JHX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008587", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004656", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEM", "relevance_score": "0.00644", "ticker_sentiment_score": "1.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00039", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKH", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.018104", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.012081", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002528", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017864", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004375", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006895", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.008331", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010551", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007688", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003421", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002207", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009462", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011915", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.00966", "ticker_sentiment_score": "-0.067565", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008956", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00507", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01589", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.046627", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010676", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.291855", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SYRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002652", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022807", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004658", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001601", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000193", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.061352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.012879", "ticker_sentiment_score": "-0.016805", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.07013", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.015306", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011352", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015702", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.295317", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HITI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009579", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.016795", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001951", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.314688", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NBSE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005048", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-1.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008158", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002177", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.422294", "ticker_sentiment_label": "Bearish"}, {"ticker": "CASI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006025", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001969", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009758", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003887", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRCL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.379884", "ticker_sentiment_label": "Bearish"}, {"ticker": "AMPS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013062", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036445", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008476", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007763", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.00322", "ticker_sentiment_score": "0.01077", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006053", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTWK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005566", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00194", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBF", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008142", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003191", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008375", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.026217", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004531", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.038289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004252", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.024299", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00208", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003016", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023636", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001062", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSWI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010534", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.349308", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMMB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000851", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.289778", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SITE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006519", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.005795", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.025041", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001118", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004295", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011008", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.102936", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00468", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002031", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.027052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004104", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.29215", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RCKT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001976", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002981", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSTK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000678", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000647", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.223806", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.26176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FROG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008082", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006139", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002993", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00473", "ticker_sentiment_label": "Neutral"}, {"ticker": "TITN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008995", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.020238", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014937", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.301571", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SUNW", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007301", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVHI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013646", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005207", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMAX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.036118", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013837", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007376", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003988", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01138", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.241618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSHA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009824", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00923", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010619", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001246", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010105", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009262", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.012879", "ticker_sentiment_score": "0.043389", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012508", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005582", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.05691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003337", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007677", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.335982", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MLNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002448", "ticker_sentiment_label": "Neutral"}, {"ticker": "EEX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.020371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TREE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001355", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.025186", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007849", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00213", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.00322", "ticker_sentiment_score": "0.031001", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.012879", "ticker_sentiment_score": "0.013326", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.052358", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.361636", "ticker_sentiment_label": "Bearish"}, {"ticker": "SWTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003614", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002191", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009634", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006603", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008334", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.029289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010461", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.005397", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010025", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.05356", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014929", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010665", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBNH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01932", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVFC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004869", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013625", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008095", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.015944", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002046", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.050789", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003323", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune: Q1 Earnings Snapshot", "url": "https://apnews.com/article/business-europe-earnings-switzerland-ac-immune-sa-c8886f155e46b0915b74b32d455a6bbc", "time_published": "20220428T125056", "authors": [], "summary": "AC Immune: Q1 Earnings Snapshot The Associated Press - en Espa\u00f1ol", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": -0.372907, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.930542", "ticker_sentiment_score": "-0.177016", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference", "url": "https://www.benzinga.com/pressreleases/22/04/g26834943/ac-immune-to-present-at-the-b-riley-annual-neuro-ophthalmology-virtual-investor-conference", "time_published": "20220427T115506", "authors": ["Globe Newswire"], "summary": "LAUSANNE, Switzerland, April  27, 2022   ( GLOBE NEWSWIRE )  -- AC Immune SA  ( NASDAQ:ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a Fireside chat and one-on-one investor", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.069758, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.487546", "ticker_sentiment_score": "0.078948", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference", "url": "https://www.globenewswire.com/news-release/2022/04/27/2430131/0/en/AC-Immune-to-Present-at-the-B-Riley-Annual-Neuro-Ophthalmology-Virtual-Investor-Conference.html", "time_published": "20220427T115500", "authors": ["AC Immune SA"], "summary": "LAUSANNE, Switzerland, April  27, 2022   ( GLOBE NEWSWIRE )  -- AC Immune SA  ( NASDAQ: ACIU ) , a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a Fireside chat and one-on-one investo", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.070003, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.447724", "ticker_sentiment_score": "0.070003", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports Changes to Senior Management", "url": "https://www.globenewswire.com/news-release/2022/04/08/2419203/0/en/AC-Immune-Reports-Changes-to-Senior-Management.html", "time_published": "20220408T113000", "authors": ["AC Immune SA"], "summary": "Howard Donovan appointed Chief HR Officer, joins executive committee", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.231586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.353333", "ticker_sentiment_score": "0.231586", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What's Behind Alzheimer's Disease?", "url": "https://www.benzinga.com/general/biotech/22/04/26498514/whats-behind-alzheimers-disease", "time_published": "20220406T133457", "authors": ["John D. Vandermosten"], "summary": "This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.\nIn our Tale of Tangles Chapter 1, theories about the underlying dysfunction of Alzheimer's disease  ( AD )  were an important guide for the development of the fi", "banner_image": "https://www.benzinga.com/files/images/2022/April/06/screenshot_2022-04-06_at_6.56.26_pm.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.024382, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.085874", "ticker_sentiment_score": "0.031638", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIVI", "relevance_score": "0.085874", "ticker_sentiment_score": "0.031638", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.085874", "ticker_sentiment_score": "0.00283", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune KOL Webinar on First Clinical Proof of Concept for Alpha-synuclein Diagnostic Shows Breakthrough Potential for Neurodegenerative diseases", "url": "https://www.globenewswire.com/news-release/2022/03/30/2412773/0/en/AC-Immune-KOL-Webinar-on-First-Clinical-Proof-of-Concept-for-Alpha-synuclein-Diagnostic-Shows-Breakthrough-Potential-for-Neurodegenerative-diseases.html", "time_published": "20220330T115800", "authors": ["AC Immune SA"], "summary": "a-syn PET tracer, ACI-12589, clinically validated in MSA, potentially enables accelerated development of targeted therapeutics and additional a-syn diagnostics", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.079116, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.498827", "ticker_sentiment_score": "0.079116", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune to Host Key Opinion Leader Webinar on Alpha-Synuclein as a Target in Neurodegenerative Diseases", "url": "https://www.globenewswire.com/news-release/2022/03/21/2406584/0/en/AC-Immune-to-Host-Key-Opinion-Leader-Webinar-on-Alpha-Synuclein-as-a-Target-in-Neurodegenerative-Diseases.html", "time_published": "20220321T113000", "authors": ["AC Immune SA"], "summary": "Webinar to take place on Tuesday, March 29th at 10:00 AM ET / 4:00 PM CET Webinar to take place on Tuesday, March 29th at 10:00 AM ET / 4:00 PM CET", "banner_image": "https://ml.globenewswire.com/Resource/Download/adf32a30-873c-44d1-9e8f-da9259565f40?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.12756, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.343211", "ticker_sentiment_score": "0.12756", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill", "url": "https://www.benzinga.com/general/biotech/22/03/26197749/the-daily-biotech-pulse-moderna-files-for-2nd-covid-booster-shot-authorization-lexicon-secures-de", "time_published": "20220318T115038", "authors": ["Shanthi Rexaline"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours.\nStocks In Focus\nLexicon Clinches Deal to Secure $150M Debt Financing For Supporting Potential Launch Of Heart Failure Drug\nLexicon Pharmaceuticals, Inc.  ( NASDAQ: LXRX )  announced an agreement relating to a loan faci", "banner_image": "https://cdn.benzinga.com/files/images/story/2012/lab-5740505_1920_11.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.041042, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.135576", "ticker_sentiment_score": "0.0032", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.135576", "ticker_sentiment_score": "0.015718", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKT", "relevance_score": "0.135576", "ticker_sentiment_score": "0.002773", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.135576", "ticker_sentiment_score": "-0.2686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMRX", "relevance_score": "0.135576", "ticker_sentiment_score": "0.001552", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.267266", "ticker_sentiment_score": "-0.00478", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKS", "relevance_score": "0.135576", "ticker_sentiment_score": "0.001474", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.135576", "ticker_sentiment_score": "0.003182", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.135576", "ticker_sentiment_score": "0.003182", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alzheimer Drugs Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis", "url": "https://www.benzinga.com/pressreleases/22/03/g26178322/alzheimer-drugs-market-size-2022-2028-industry-size-share-growth-trends-forecast-analysis", "time_published": "20220317T094130", "authors": ["Globe Newswire"], "summary": "Pune, India, March  17, 2022   ( GLOBE NEWSWIRE )  -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer's drugs which in turn is driving the global Alzheimer Drugs Market, says Fortune Business Insights in a report, titled Alzheimer Drugs Market Size, Share and Global ", "banner_image": "https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.072891, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.036053", "ticker_sentiment_score": "0.091534", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.072032", "ticker_sentiment_score": "-0.132033", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.036053", "ticker_sentiment_score": "0.141659", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.072032", "ticker_sentiment_score": "-0.132033", "ticker_sentiment_label": "Neutral"}]}, {"title": "AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference", "url": "https://www.globenewswire.com/news-release/2022/03/16/2404270/0/en/AC-Immune-Reports-First-Live-Images-of-Alpha-Synuclein-in-Human-Brain-with-New-PET-Tracer-for-Neurodegenerative-Disease-at-AD-PDTM-Conference.html", "time_published": "20220316T114100", "authors": ["AC Immune SA"], "summary": "ACI-12589 distinguished multiple system atrophy  ( MSA )  from other a-synucleinopathies and healthy volunteers", "banner_image": "https://ml.globenewswire.com/Resource/Download/10e79976-ac90-44b1-83f3-ad7e65204765?size=2", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.126111, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.331009", "ticker_sentiment_score": "0.126111", "ticker_sentiment_label": "Neutral"}]}]}